Palantir (PLTR) 10-K20 Feb 242023 FY Annual reportFinancial data

Company Profile

Cover Page

Cover Page - USD ($) $ in Billions	12 Months Ended
Cover Page - USD ($) $ in Billions	Dec. 31, 2023	Feb. 13, 2024	Jun. 30, 2023
Document Information [Line Items]
Document Type	10-K
Document Quarterly Report	true
Current Fiscal Year End Date	--12-31
Document Period End Date	Dec. 31, 2023
Document Transition Report	false
Entity File Number	001-39540
Entity Registrant Name	Palantir Technologies Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	68-0551851
Entity Address, Address Line One	1200 17th Street, Floor 15
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80202
City Area Code	(720)
Local Phone Number	358-3679
Title of 12(b) Security	Class A Common Stock, par value $0.001 per share
Trading Symbol	PLTR
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction	false
Entity Shell Company	false
Entity Public Float			$ 29.3
Documents Incorporated by Reference	Documents Incorporated by Reference Portions of the registrant’s Definitive Proxy Statement relating to the Annual Meeting of Stockholders to be held in 2024 are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant’s fiscal year ended December 31, 2023.
Entity Central Index Key	0001321655
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Amendment Flag	false
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		2,110,901,985
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		100,826,007
Class F Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,005,000

Audit Information

Audit Information	12 Months Ended
Audit Information	Dec. 31, 2023
Audit Information [Abstract]
Auditor Firm ID	42
Auditor Name	Ernst & Young LLP
Auditor Location	San Jose, California

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 831,047	$ 2,598,540
Marketable securities	2,843,132	35,135
Accounts receivable, net	364,784	258,346
Prepaid expenses and other current assets	99,655	149,556
Total current assets	4,138,618	3,041,577
Property and equipment, net	47,758	69,170
Operating lease right-of-use assets	182,863	200,240
Other assets	153,186	150,252
Total assets	4,522,425	3,461,239
Current liabilities:
Accounts payable	12,122	44,788
Accrued liabilities	222,991	172,715
Deferred revenue	246,901	183,350
Customer deposits	209,828	141,989
Operating lease liabilities	54,176	45,099
Total current liabilities	746,018	587,941
Deferred revenue, noncurrent	28,047	9,965
Customer deposits, noncurrent	1,477	3,936
Operating lease liabilities, noncurrent	175,216	204,305
Other noncurrent liabilities	10,702	12,655
Total liabilities	961,460	818,802
Commitments and Contingencies (Note 8)
Stockholders’ equity:
Common stock	2,200	2,099
Additional paid-in capital	9,122,173	8,427,998
Accumulated other comprehensive income (loss), net	801	(5,333)
Accumulated deficit	(5,649,613)	(5,859,438)
Total stockholders’ equity	3,475,561	2,565,326
Noncontrolling interests	85,404	77,111
Total equity	3,560,965	2,642,437
Total liabilities and equity	$ 4,522,425	$ 3,461,239

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2023	Dec. 31, 2022
Common stock, shares authorized (in shares)	22,701,005,000	22,701,005,000
Common stock, shares issued (in shares)	2,200,128,000	2,099,075,000
Common stock, shares outstanding (in shares)	2,200,128,000	2,099,075,000
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	20,000,000,000	20,000,000,000
Common stock, shares issued (in shares)	2,096,982,000	1,995,414,000
Common stock, shares outstanding (in shares)	2,096,982,000	1,995,414,000
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	2,700,000,000	2,700,000,000
Common stock, shares issued (in shares)	102,141,000	102,656,000
Common stock, shares outstanding (in shares)	102,141,000	102,656,000
Class F Common Stock
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	1,005,000	1,005,000
Common stock, shares issued (in shares)	1,005,000	1,005,000
Common stock, shares outstanding (in shares)	1,005,000	1,005,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenue	$ 2,225,012	$ 1,905,871	$ 1,541,889
Cost of revenue	431,105	408,549	339,404
Gross profit	1,793,907	1,497,322	1,202,485
Operating expenses:
Sales and marketing	744,992	702,511	614,512
Research and development	404,624	359,679	387,487
General and administrative	524,325	596,333	611,532
Total operating expenses	1,673,941	1,658,523	1,613,531
Income (loss) from operations	119,966	(161,201)	(411,046)
Interest income	132,572	20,309	1,607
Interest expense	(3,470)	(4,058)	(3,640)
Other income (expense), net	(11,977)	(216,077)	(75,415)
Income (loss) before provision for income taxes	237,091	(361,027)	(488,494)
Provision for income taxes	19,716	10,067	31,885
Net income (loss)	217,375	(371,094)	(520,379)
Less: Net income attributable to noncontrolling interests	7,550	2,611	0
Net income (loss) attributable to common stockholders	$ 209,825	$ (373,705)	$ (520,379)
Net earnings (loss) per share attributable to common stockholders, basic (in dollars per share)	$ 0.10	$ (0.18)	$ (0.27)
Net earnings (loss) per share attributable to common stockholders, diluted (in dollars per share)	$ 0.09	$ (0.18)	$ (0.27)
Weighted-average shares of common stock outstanding used in computing net earnings (loss) per share attributable to common stockholders, basic (in shares)	2,147,446	2,063,793	1,923,617
Weighted-average shares of common stock outstanding used in computing net earnings (loss) per share attributable to common stockholders, diluted (in shares)	2,297,927	2,063,793	1,923,617

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 217,375	$ (371,094)	$ (520,379)
Other comprehensive income (loss)
Foreign currency translation adjustments	2,699	(2,984)	396
Net unrealized gain (loss) on available-for-sale securities	3,435	0	0
Comprehensive income (loss)	223,509	(374,078)	(519,983)
Less: Comprehensive income attributable to noncontrolling interests	7,550	2,611	0
Comprehensive income (loss) attributable to common stockholders	$ 215,959	$ (376,689)	$ (519,983)

Consolidated Statements of Stoc

Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss), Net	Accumulated Deficit	Parent	Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2020		1,792,140,000
Beginning balance at Dec. 31, 2020	$ 1,522,550	$ 1,792	$ 6,488,857	$ (2,745)	$ (4,965,354)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from the exercise of stock options (in shares)		178,849,000
Issuance of common stock from the exercise of stock options	507,455	$ 178	507,277
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares)		50,350,000
Issuance of common stock upon vesting of restricted stock units (“RSUs”)	0	$ 50	(50)
Issuance of common stock upon vesting of growth units (shares)		1,471,000
Issuance of common stock upon vesting of growth units	0	$ 1	(1)
Issuance of common stock upon net exercise of common stock warrants and other (in shares)		4,664,000
Issuance of common stock upon net exercise of common stock warrants and other	1,712	$ 6	1,706
Stock-based compensation	779,296		779,296
Other comprehensive income (loss)	396			396
Net income (loss)	(520,379)				(520,379)
Ending balance (in shares) at Dec. 31, 2021		2,027,474,000
Ending balance at Dec. 31, 2021	2,291,030	$ 2,027	7,777,085	(2,349)	(5,485,733)	$ 2,291,030	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from the exercise of stock options (in shares)		19,660,000
Issuance of common stock from the exercise of stock options	86,088	$ 20	86,068			86,088
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares)		51,941,000
Issuance of common stock upon vesting of restricted stock units (“RSUs”)	0	$ 52	(52)
Stock-based compensation	564,897		564,897			564,897
Other comprehensive income (loss)	(2,984)			(2,984)		(2,984)
Noncontrolling interests	74,500						74,500
Net income (loss)	$ (371,094)				(373,705)	(373,705)	2,611
Ending balance (in shares) at Dec. 31, 2022	2,099,075,000	2,099,075,000
Ending balance at Dec. 31, 2022	$ 2,642,437	$ 2,099	8,427,998	(5,333)	(5,859,438)	2,565,326	77,111
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from the exercise of stock options (in shares)	46,079,000	46,079,000
Issuance of common stock from the exercise of stock options	$ 218,238	$ 46	218,192			218,238
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares)		54,974,000
Issuance of common stock upon vesting of restricted stock units (“RSUs”)	0	$ 55	(55)
Stock-based compensation	476,038		476,038			476,038
Other comprehensive income (loss)	6,134			6,134		6,134
Other, net	743						743
Net income (loss)	$ 217,375				209,825	209,825	7,550
Ending balance (in shares) at Dec. 31, 2023	2,200,128,000	2,200,128,000
Ending balance at Dec. 31, 2023	$ 3,560,965	$ 2,200	$ 9,122,173	$ 801	$ (5,649,613)	$ 3,475,561	$ 85,404

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Operating activities
Net income (loss)	$ 217,375	$ (371,094)	$ (520,379)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	33,354	22,522	14,897
Stock-based compensation	475,903	564,798	778,215
Deferred income taxes	(4,806)	(174)	43,316
Noncash operating lease expense	47,019	40,309	33,821
Unrealized and realized (gain) loss from marketable securities, net	13,160	272,108	73,311
Noncash consideration	(46,609)	(15,537)	0
Gain from step acquisition	0	(44,306)	0
Other operating activities	(29,449)	16,328	2,767
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net	(106,159)	(72,819)	(35,237)
Prepaid expenses and other current assets	(6,197)	(24,811)	(10,974)
Other assets	3,242	6,033	(3,345)
Accounts payable	(31,832)	(29,859)	57,767
Accrued liabilities	52,895	5,527	15,245
Deferred revenue, current and noncurrent	79,512	(61,154)	24,732
Customer deposits, current and noncurrent	64,347	(49,471)	(104,944)
Operating lease liabilities, current and noncurrent	(49,630)	(34,590)	(32,156)
Other noncurrent liabilities	58	(73)	(3,185)
Net cash provided by operating activities	712,183	223,737	333,851
Investing activities
Purchases of property and equipment	(15,114)	(40,027)	(12,627)
Purchases of marketable securities	(5,636,406)	(124,500)	(308,315)
Proceeds from sales and redemption of marketable securities	2,889,268	52,319	851
Business combinations, net of cash acquired	0	66,708	0
Purchases of alternative investments	0	0	(50,941)
Proceeds from sales of alternative investments	51,072	0	0
Purchases of privately-held securities	0	0	(23,009)
Other investing activities	0	73	(3,871)
Net cash used in investing activities	(2,711,180)	(45,427)	(397,912)
Financing activities
Principal payments on borrowings	0	0	(200,000)
Proceeds from the exercise of common stock options	218,238	86,089	507,455
Other financing activities	601	(93)	(708)
Net cash provided by financing activities	218,839	85,996	306,747
Effect of foreign exchange on cash, cash equivalents, and restricted cash	2,930	(3,885)	(3,918)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(1,777,228)	260,421	238,768
Cash, cash equivalents, and restricted cash - beginning of period	2,627,335	2,366,914	2,128,146
Cash, cash equivalents, and restricted cash - end of period	850,107	2,627,335	2,366,914
Supplemental disclosures of cash flow information
Cash paid for income taxes	$ 13,515	$ 2,904	$ 4,131

Organization

Organization	12 Months Ended
Organization	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Organization Palantir Technologies Inc. (including its subsidiaries, “Palantir” or the “Company”) was incorporated in Delaware on May 6, 2003. The Company builds and deploys software platforms that serve as the central operating systems for its customers.

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
Significant Accounting Policies	Dec. 31, 2023
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Basis of Presentation and Consolidation The accompanying consolidated financial statements have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission regarding annual financial reporting. The accompanying consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investments in entities where the Company holds at least a 20% ownership interest and has the ability to exercise significant influence over, but does not control, the investee are accounted for using the equity method of accounting. Certain prior year balances have been reclassified to conform to the current year presentation. Such reclassifications did not affect total revenues, income (loss) from operations, net income (loss), or cash flows. The Company’s fiscal year ends on December 31. Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions made in the accompanying consolidated financial statements include, but are not limited to, the identification of performance obligations in customer contracts, the valuation of deferred tax assets and uncertain tax positions, and the collectability of contract consideration, including accounts receivable. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations. Segments The Company has two operating segments, commercial and government, which were determined based on the manner in which the chief operating decision maker (“CODM”), who is the Chief Executive Officer, manages the operations of the Company for purposes of allocating resources and evaluating performance. Various factors, including the Company’s organizational and management reporting structure and customer type, were considered in determining these operating segments. The Company’s operating segments are described below: • Commercial: This segment primarily serves customers working in non-government industries. • Government: This segment primarily serves customers that are United States (“U.S.”) government and non-U.S. government agencies. Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of amounts invested in money market funds and available-for-sale debt securities. Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the amounts shown in the consolidated statements of cash flows (in thousands): As of December 31, 2023 2022 2021 Cash and cash equivalents $ 831,047 $ 2,598,540 $ 2,290,674 Restricted cash included in prepaid expenses and other current assets 370 16,244 36,628 Restricted cash included in other assets 18,690 12,551 39,612 Total cash, cash equivalents, and restricted cash $ 850,107 $ 2,627,335 $ 2,366,914 Accounts Receivable and Allowance for Credit Losses Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. The Company generally grants non-collateralized credit terms to its customers. Allowance for credit losses is based on the Company’s best estimate of probable losses inherent in its accounts receivable portfolio and is determined based on expectations of the customer’s ability to pay by considering factors such as customer type (commercial or government), historical experience, financial position of the customer, age of the accounts receivable, current economic conditions, and reasonable and supportable forward-looking factors about its portfolio and future economic conditions. Accounts receivable are written-off and charged against an allowance for credit losses when the Company has exhausted collection efforts without success. Based upon the Company’s assessment as of December 31, 2023 and 2022, the Company recorded an allowance for credit losses of $10.5 million and $10.1 million, respectively. Debt Securities Debt securities are primarily comprised of U.S. treasury securities. The debt securities are classified as available-for-sale at the time of purchase and are reevaluated as of each balance sheet date. The Company considers the majority of its available-for-sale debt securities as available for use in current operations and may sell these securities at any time, and therefore classifies these securities as current assets in its consolidated balance sheets. Debt securities included in marketable securities on the consolidated balance sheets consist of U.S. treasury securities with original maturities of greater than three months at the time of purchase, and the remaining U.S. treasury securities are included in cash and cash equivalents. Interest income on debt securities is included in other income (expense), net on the consolidated statements of operations. The majority of the Company’s available-for-sale securities are recorded at fair value each reporting period using quoted prices of similar instruments and are classified within Level 2 of the fair value hierarchy. The Company evaluates investments with unrealized loss positions for other than temporary impairment by assessing if they are related to deterioration in credit risk and whether it expects to recover the entire amortized cost basis of the security, the Company’s intent to sell, and whether it is more likely than not that the Company will be required to sell the securities before the recovery of their cost basis. Credit-related impairment losses, not to exceed the amount that fair value is less than the amortized cost basis, are recognized in other income (expense), net in the consolidated statements of operations. Unrealized gains and non-credit related losses are reported as a separate component of accumulated other comprehensive loss, net in the consolidated balance sheets until realized. Realized gains and losses and declines in value judged to be other than temporary are determined based on the specific identification method and are reported in other income (expense), net in the consolidated statements of operations. Concentrations of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, accounts receivable, marketable securities, and privately-held equity securities. Cash equivalents primarily consist of money market funds and U.S. treasury securities with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts. The Company is exposed to concentrations of credit risk with respect to accounts receivable presented in the consolidated balance sheets. The Company’s accounts receivable balances as of December 31, 2023 and 2022 were $364.8 million and $258.3 million, respectively. Customer I represented 15% of total accounts receivable as of December 31, 2023, and no other customer represented more than 10% of total accounts receivable as of December 31, 2023. No customer represented more than 10% of total accounts receivable as of December 31, 2022. For the years ended December 31, 2023, 2022, and 2021, no customer represented 10% or more of total revenue. Alternative Investments Alternative investments include gold bars and are recorded in prepaid expenses and other current assets on the consolidated balance sheets. The investments are initially recorded at cost and subsequently remeasured at the lower of cost or market each reporting period. Market value is determined by using quoted market prices of identical or similar assets from active markets. Unrealized losses are recorded in other income (expense), net in the consolidated statements of operations. Realized gains and losses are recorded in other income (expense), net upon realization. Property and Equipment, Net Property and equipment, net are stated at cost less accumulated depreciation and amortization. Depreciation is recognized using the straight-line method over the estimated useful lives of the respective assets, which are generally three years. Leasehold improvements are capitalized and amortized using the straight-line method over the shorter of the remaining lease term or the estimated useful life, which is generally five years. Maintenance and repairs that do not improve or extend the useful lives of the assets are expensed when incurred. Upon sale or retirement of assets, the cost and related accumulated depreciation and amortization are derecognized from the consolidated balance sheets and any resulting gain or loss is recorded in the consolidated statements of operations in the period realized. Privately-held Equity Securities Equity securities in privately-held companies without readily determinable fair values are recorded using the measurement alternative. Such investments are carried at cost, less any impairments, and are adjusted for subsequent observable price changes in orderly transactions for identical or similar investments of the same issuer. Changes in the basis of the equity securities are recognized in other income (expense), net in the consolidated statements of operations. Business Combinations Business combinations are accounted for using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) 805, Business Combinations, and are included in our consolidated financial statements from their respective acquisition dates. Assets acquired and liabilities assumed, if any, are measured at fair value on the acquisition date using the appropriate valuation method. Goodwill generated from acquisitions is recognized if the fair value of the purchase consideration transferred, or the fair value of the acquirer’s interest in the acquiree if no consideration is transferred, and any noncontrolling interests is in excess of the net fair value of the identifiable assets acquired and the liabilities assumed. In determining the fair value of identifiable assets, we use various valuation techniques which require us to make estimates and assumptions surrounding projected revenues and costs, future growth, and discount rates. Goodwill Goodwill represents the excess of the fair value of the purchase consideration transferred, or the fair value of the acquirer’s interest in the acquiree if no consideration is transferred, and any noncontrolling interests over the net fair value of the identifiable assets acquired and the liabilities assumed in business combinations. Goodwill is not amortized but is subject to an annual impairment test. We perform our annual goodwill impairment assessment on the first day of the fourth quarter. Tests are performed more frequently if events occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Goodwill is recorded in other assets in the consolidated balance sheet. Other Intangible Assets Other intangible assets include finite-lived intangible assets, which mainly consist of customer relationships, reacquired rights, and backlog. These assets are amortized over their estimated useful lives and are tested for impairment using a similar methodology to our property and equipment, as described below. Other intangible assets are recorded in other assets in the consolidated balance sheets. Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment annually or whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability is measured by comparing the carrying amount of an asset to the future undiscounted cash flows that the asset is expected to generate. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Impairments of long-lived assets during the years ended December 31, 2023, 2022, and 2021 were not material. Leases The Company determines if an arrangement is a lease at inception. An arrangement is or contains a lease if it conveys the right to control the use of an identified asset for a period of time in exchange for consideration. If a lease is identified, classification is determined at lease commencement. Operating lease liabilities are recognized at the present value of the future lease payments at the lease commencement date. The Company’s leases do not provide an implicit interest rate and therefore the Company estimates its incremental borrowing rate to discount lease payments. The incremental borrowing rate reflects the interest rate that the Company would have to pay to borrow on a collateralized basis an amount equal to the lease payments in a similar economic environment over a similar term. Operating lease right-of-use (“ROU”) assets are based on the corresponding lease liability adjusted for any lease payments made at or before commencement, initial direct costs, and lease incentives. Renewals or early terminations are not accounted for unless the Company is reasonably certain to exercise these options. Operating lease expense is recognized and the ROU asset is amortized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component. For short-term leases, defined as leases with a term of twelve months or less, the Company elected the practical expedient to not recognize an associated lease liability and ROU asset. Lease payments for short-term leases are expensed on a straight-line basis over the lease term. Operating leases are included in operating lease right-of-use assets, operating lease liabilities, and operating lease liabilities, non-current on the Company’s consolidated balance sheets. Finance leases are not material. Fair Value Measurement Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, or an exit price, in the principal or most advantageous market for that asset or liability in an orderly transaction between market participants on the measurement date. The Company measures fair value based on a three-level hierarchy of inputs, maximizing the use of observable inputs, where available, and minimizing the use of unobservable inputs when measuring fair value. A financial instrument’s level within the three-level hierarchy is based on the lowest level of input that is significant to the fair value measurement. The three-level hierarchy of inputs is as follows: Level 1: Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. These inputs are based on the Company’s own assumptions about current market conditions and require significant management judgment or estimation. Financial instruments consist of money market funds and certificates of deposit included in cash equivalents and restricted cash, accounts receivable, marketable securities, other assets accounted for at fair value, accounts payable, and accrued liabilities. Money market funds, certificates of deposit, and marketable securities are stated at fair value on a recurring basis. Accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. Revenue Recognition The Company generates revenue from the sale of subscriptions to access its software platforms in the Company’s hosted environment, along with ongoing operations and maintenance (“O&M”) services (“Palantir Cloud”); software licenses, primarily term licenses in the customers’ environments, with ongoing O&M services (“On-Premises Software”); and professional services. In accordance with ASC 606, Revenue from Contracts with Customers , the Company recognizes revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company applies the following five-step revenue recognition model in accounting for its revenue arrangements: • Identification of the contract(s) with the customer, including whether collectability of the consideration is probable by considering the customers’ ability and intention to pay; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, the Company satisfies a performance obligation. Additionally, the pricing of the Company’s contracts is generally fixed; however, it is possible for contracts to include variable consideration, which can be based on subjective or objective criteria. The Company includes the estimated amount of variable consideration that it expects to receive to the extent it is probable that a significant revenue reversal will not occur. Each of the Company’s significant performance obligations and the Company’s application of ASC 606 to its revenue arrangements is discussed in further detail below. Palantir Cloud The Company’s Palantir Cloud subscriptions grant customers the right to access the software functionality in a hosted environment controlled by Palantir and are sold together with stand-ready O&M services, as further described below. The Company agrees to provide continuous access to its hosted software platforms throughout the contract term. Revenue associated with Palantir Cloud subscriptions is generally recognized over the contract term on a ratable basis, which is consistent with the transfer of control of the Palantir Cloud subscription to the customer. On-Premises Software Sales of the Company’s software licenses, primarily term licenses, grant customers the right to use functional intellectual property, either on their internal hardware infrastructure or on their own cloud instance, over the contractual term and are also sold together with stand-ready O&M services. The O&M services include critical updates, support, and maintenance services required to operate the software and, as such, are necessary for the software to maintain its intended utility over the contractual term. Because of this requirement, the Company has concluded that the software licenses and O&M services, which together the Company refers to as On-Premises Software, are highly interdependent and interrelated and represent a single distinct performance obligation within the context of the contract. Revenue is generally recognized over the contract term on a ratable basis. Professional Services The Company’s professional services support the customers’ use of the software platforms and include, as needed, on-demand user support, user-interface configuration, training, and ongoing ontology and data modeling support. Professional services contracts typically include the provision of on-demand professional services for the duration of the contractual term. These services are typically coterminous with a Palantir Cloud subscription or the On-Premises Software. Professional services are on-demand, whereby the Company performs services throughout the contract period; therefore, the revenue is recognized over the contractual term. Contract Liabilities The timing of customer billings and payments relative to the start of the service period varies from contract to contract; however, the Company bills many of its customers in advance of the provision of services under its contracts, resulting in contract liabilities consisting of either deferred revenue or customer deposits (“contract liabilities”). Deferred revenue represents billings under noncancelable contracts before the related product or service is transferred to the customer. Customer deposits consist of amounts billed and/or paid in advance of the start of the contractual term or for anticipated revenue generating activities for the portion of a contract term that is subject to cancellation by its customers. Many of the Company’s arrangements include terms that allow the customer to terminate the contract for convenience and receive a pro-rata refund of the amount of the customer deposit for the period of time remaining in the contract term after the applicable termination notice period expires. In these arrangements, the Company concluded there are no enforceable rights and obligations after such notice period and therefore the consideration received or due from the customer that is subject to termination for convenience is recorded as customer deposits. The payment terms and conditions vary by contract; however, the Company’s terms generally require payment within 30 to 60 days from the invoice date. In instances where the timing of revenue recognition differs from the timing of payment, the Company elected to apply the practical expedient in accordance with ASC 606 to not adjust contract consideration for the effects of a significant financing component as the Company expects, at contract inception, that the period between when promised goods and services are transferred to the customer and when the customer pays for those goods and services will be one year or less. As such, the Company determined its contracts do not generally contain a significant financing component. Areas of Judgment and Estimation The Company’s contracts with customers can include multiple promises to transfer goods or services to the customer. Determining whether promises are distinct performance obligations that should be accounted for separately – or not distinct within the context of the contract and, thus, accounted for together – requires significant judgment. The Company concluded that the promise to provide a software license is highly interdependent and interrelated with the promise to provide O&M services and such promises are not distinct within the context of its contracts and are accounted for as a single performance obligation as the Company’s On-Premises Software. Significant estimates and assumptions are used in the identification of performance obligations in customer contracts and collectability of contract consideration, including accounts receivable. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect our financial position and results of operations. Costs to Obtain and Fulfill Contracts Incremental costs of obtaining a contract include only those costs that are directly related to the acquisition of contracts, including sales commissions, and that would not have been incurred if the contract had not been obtained. The Company recognizes a contract cost asset for the incremental costs of obtaining a contract with a customer if it is expected that the economic benefit and amortization period will be longer than one year. Costs to obtain contracts were not material in the periods presented. The Company recognizes an asset for the costs to fulfill a contract with a customer if the costs are specifically identifiable, generate or enhance resources used to satisfy future performance obligations, and are expected to be recovered. Costs to fulfill contracts were not material in the periods presented. Software Development Costs The Company evaluates capitalization of certain software development costs subsequent to the establishment of technological feasibility. Based on the Company’s product development process and substantial development risks, technological feasibility is generally established for the Company’s products when they are made available for general release. Accordingly, most costs are charged to research and development expense in the period incurred. Cost of Revenue Cost of revenue primarily includes salaries, stock-based compensation expense, and benefits for personnel involved in performing O&M and professional services, as well as field service representatives, third-party cloud hosting services, travel costs, allocated overhead, and other direct costs. Sales and Marketing Costs Sales and marketing costs primarily include salaries, stock-based compensation expense, commissions, and benefits for the sales force and personnel involved in sales functions, executing on pilots, including bootcamps, and performing other brand building and customer growth activities, as well as third-party cloud hosting services for pilots, marketing and sales event-related costs, travel costs, and allocated overhead. The Company generally charges all such costs to sales and marketing expense in the period incurred. Advertising costs are expensed as incurred and included in sales and marketing expense within the consolidated statements of operations. Advertising expense totaled $21.4 million, $38.6 million, and $26.3 million for the years ended December 31, 2023, 2022, and 2021, respectively. Research and Development Costs Research and development costs primarily include salaries, stock-based compensation expense, and benefits for personnel involved in performing the activities to develop and refine the Company’s platforms and products, as well as third-party cloud hosting services and other IT related costs, travel costs, and allocated overhead. Research and development costs are expensed as incurred. Commitments and Contingencies Liabilities for loss contingencies arising from claims, disputes, legal proceedings, fines and penalties, and other sources are recorded when it is probable that a liability has been or will be incurred and the amount of the liability can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred. Recoveries of such legal costs from insurance policies are recorded as an offset to legal expenses in the period they are received. Stock-Based Compensation The Company accounts for stock-based compensation expense in accordance with the fair value recognition and measurement provisions of GAAP, which require compensation cost for the grant-date fair value of stock-based awards to be recognized over the requisite service period. The Company determines the fair value of stock-based awards granted or modified on the grant date or modification date using appropriate valuation techniques. The Company recognizes forfeitures as they occur. Service-Based Vesting The Company grants RSUs and stock option awards that vest based upon the satisfaction of only a service condition. For RSUs, the Company determines the grant-date fair value of the RSUs as the fair value of the Company’s common stock on the grant date. The Company records stock-based compensation expense for stock options and RSUs that vest based upon the satisfaction of only a service condition on a straight-line basis over the requisite service period, which is generally one Performance-Based Vesting The Company also grants awards, including RSUs, that vest upon the satisfaction of both a service condition and a performance condition. The Company determines the grant-date fair value of RSUs with both a service-based vesting condition and a performance-based vesting condition as the fair value of the Company’s common stock on the grant date and records stock-based compensation expense using the accelerated attribution method over the service period. The performance-based vesting condition for the RSUs granted prior to September 30, 2020, the date the Company completed a direct listing of its Class A common stock on the New York Stock Exchange (the “Direct Listing”) was satisfied upon the occurrence of the Company’s Direct Listing. For performance-based RSUs granted after the Direct Listing (“P-RSUs”), the Company recognizes expense from the number of P-RSUs expected to vest, determined based on the level of achievement against certain performance conditions, over the requisite service period when it is probable that the performance condition will be achieved. The probability of achievement is assessed periodically to determine whether the performance metric continues to be probable. When there is a change in the assessment of the probability of achievement, any cumulative effect of the change is recognized in the period of the change and any remaining expense of the related awards is amortized over the remaining service period. Employee Benefit Plan The Company sponsors a 401(k) tax-deferred savings plan for all employees who meet certain eligibility requirements. Participants may contribute, on a pretax and post-tax basis, a percentage of their qualifying annual compensation, but not to exceed a maximum contribution amount pursuant to Section 401(k) of the Internal Revenue Code. The Company may make additional matching contributions on behalf of the participants. The Company did not make matching contributions for the years ended December 31, 2023, 2022, and 2021. Income Taxes The Company estimates its current tax expense together with assessing temporary differences resulting from differing treatment of items not currently deductible for tax purposes. These differences result in deferred tax assets and liabilities on the Company’s consolidated balance sheets, which are estimated based upon the difference between the financial statement and tax bases of assets and liabilities using the enacted tax rates that will be in effect when these differences reverse. In general, deferred tax assets represent future tax benefits to be received when certain expenses previously recognized in the Company’s consolidated statements of operations become deductible expenses under applicable income tax laws or loss or credit carryforwards are utilized. Accordingly, the realization of the Company’s deferred tax assets is dependent on future taxable income against which these deductions, losses, and credits can be utilized. The Company evaluates the realizability of its deferred tax assets and recognizes a valuation allowance when it is more likely than not that a future benefit on such deferred tax assets will not be realized. The Company considers all evidence, both positive and negative, in determining any required valuation allowance and evaluates the need for a valuation allowance on a regular basis. The Company performs an assessment of both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. Such assessment is required on a jurisdiction by jurisdiction basis. The Company reviews the recognition of deferred tax assets on a regular basis to determine if realization of such assets is more likely than not. A valuation

Contract Liabilities and Remain

Contract Liabilities and Remaining Performance Obligations	12 Months Ended
Contract Liabilities and Remaining Performance Obligations	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Contract Liabilities and Remaining Performance Obligations	Contract Liabilities and Remaining Performance Obligations Contract Liabilities The Company’s contract liabilities consist of deferred revenue and customer deposits. As of December 31, 2023 and 2022, the Company’s contract liability balances were $486.3 million and $339.2 million, respectively. Revenue of $329.4 million and $384.3 million was recognized during the years ended December 31, 2023 and 2022, respectively, that was included in the contract liabilities balances as of December 31, 2022 and 2021, respectively. Remaining Performance Obligations The Company’s arrangements with its customers often have terms that span over multiple years. However, the Company allows many of its customers to terminate contracts for convenience prior to the end of the stated term with less than twelve months’ notice. Revenue allocated to remaining performance obligations represents noncancelable contracted revenue that has not yet been recognized, which includes deferred revenue and, in certain instances, amounts that will be invoiced. The Company has elected the practical expedient allowing the Company to not disclose remaining performance obligations for contracts with original terms of twelve months or less. Cancelable contracted revenue, which includes customer deposits, is not considered a remaining performance obligation. The Company’s remaining performance obligations were $1.2 billion as of December 31, 2023, of which the Company expects to recognize approximately 52% as revenue over the next 12 months, 37% as revenue over the subsequent 13 to 36 months, and the remainder thereafter. Disaggregation of Revenue See Note 13. Segment and Geographic Information for disaggregated revenue by customer segment and geographic region.

Investments and Fair Value Meas

Investments and Fair Value Measurements	12 Months Ended
Investments and Fair Value Measurements	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Investments and Fair Value Measurements	Investments and Fair Value Measurements The following tables present the Company’s assets that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation (in thousands): As of December 31, 2023 Total Level 1 Level 2 Level 3 Assets: Cash and cash equivalents: Money market funds $ 576,565 $ 576,565 $ — $ — U.S. treasury securities 10,079 — 10,079 — Certificates of deposit 938 — 938 — Prepaid expenses and other current assets and other assets: Certificates of deposit 4,777 — 4,777 — Marketable securities: U.S. treasury securities 2,824,861 — 2,824,861 — Publicly-traded equity securities 18,271 18,271 — — Total $ 3,435,491 $ 594,836 $ 2,840,655 $ — As of December 31, 2022 Total Level 1 Level 2 Level 3 Assets: Cash and cash equivalents: Money market funds $ 1,149,302 $ 1,149,302 $ — $ — Certificates of deposit 6,791 — 6,791 — Prepaid expenses and other current assets and other assets: Certificates of deposit 18,707 — 18,707 — Marketable securities: Publicly-traded equity securities 35,135 35,135 — — Total $ 1,209,935 $ 1,184,437 $ 25,498 $ — Certificates of Deposit The Company’s certificates of deposit are Level 2 instruments. The fair value of such instruments is estimated based on valuations obtained from third-party pricing services that utilize industry standard valuation models, including both income-based and market-based approaches, for which all significant inputs are observable either directly or indirectly. These inputs include interest rate curves, foreign exchange rates, and credit ratings. Debt Securities As of December 31, 2023, available-for-sale debt securities consisted of the following (in thousands): As of December 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 2,831,505 $ 4,520 $ (1,085) $ 2,834,940 Total debt securities $ 2,831,505 $ 4,520 $ (1,085) $ 2,834,940 Included in cash and cash equivalents $ 10,078 $ 1 $ — $ 10,079 Included in marketable securities $ 2,821,427 $ 4,519 $ (1,085) $ 2,824,861 The Company sold $694.6 million of available-for-sale debt securities during the fiscal year ended December 31, 2023 and immediately reinvested such proceeds into additional available-for-sale debt securities. The realized gains and losses from those sales were immaterial. No credit or non-credit losses related to available-for sale debt securities were recorded as of December 31, 2023. As of December 31, 2023, available-for-sale debt securities of $236.0 million were in an unrealized loss position primarily due to unfavorable changes in interest rates subsequent to initial purchase. None of the available-for-sale debt securities held as of December 31, 2023 were in a continuous unrealized loss position for greater than 12 months. The decline in fair value below amortized cost basis was not considered other than temporary as it is more likely than not that the Company will hold the securities until maturity or a recovery of the cost basis, and no credit-related impairment losses were recorded as of December 31, 2023. All of the Company’s U.S. treasury securities had contractual maturities due within one year as of December 31, 2023. As of December 31, 2022, the Company held an immaterial amount of debt securities. Equity Securities The Company has equity securities consisting of shares held in publicly-traded companies, which are recorded at fair market value each reporting period within marketable securities in the consolidated balance sheets. Additionally, we have accepted, and may continue to accept, securities as noncash consideration. Total equity securities received as noncash consideration was $41.7 million, $6.8 million, and an immaterial amount during the years ended December 31, 2023, 2022, and 2021, respectively. Realized and unrealized gains and losses are recorded in other income (expense), net in the consolidated statements of operations. During the years ended December 31, 2022 and 2021, the Company recorded net unrealized losses of $159.0 million and $72.8 million, respectively, and realized losses of $113.1 million and an immaterial amount during the years ended December 31, 2022 and 2021, respectively, for its publicly-traded equity securities. For the years ended December 31, 2023, 2022, and 2021 net unrealized losses from publicly-traded equity securities held at the end of each period were $4.5 million, $197.3 million, and $72.8 million respectively. The Company also has equity securities in privately-held companies without readily determinable fair values that are recorded using the measurement alternative. As of December 31, 2023 and December 31, 2022, the total amount of privately-held equity securities included in other assets on the consolidated balance sheets was $32.6 million and $24.4 million, respectively. The Company classifies these fair value measurements as Level 3 within the fair value hierarchy. The Company did not record any material adjustments or impairments for the privately-held equity securities held as of December 31, 2023 and December 31, 2022. Investments From 2021 through 2022, the Company approved and entered into certain agreements (“Investment Agreements”) to purchase shares of various entities, including special purpose acquisition companies and/or other privately-held or publicly-traded entities (each, an “Investee,” and such purchases, the “Investments”). During the year ended December 31, 2022, the Company purchased shares for a total investment of $124.5 million. No Investments were purchased under such Investment Agreements during the fiscal year ended December 31, 2023. In connection with signing the Investment Agreements, each Investee or an associated entity and the Company entered into a commercial contract for access to the Company’s products and services (collectively, the “Strategic Commercial Contracts”). The Company assesses the concurrent agreements under the noncash and consideration paid or payable to a customer guidance within ASC 606, Revenue from Contracts with Customers, as well as the commercial substance of each arrangement considering the customer’s ability and intention to pay as well as the Company’s obligation to perform under each contract. As currently assessed, the total value of Strategic Commercial Contracts was $376.5 million as of December 31, 2023, which is inclusive of $40.4 million of contractual options. The original terms of the Strategic Commercial Contracts with remaining deal value as of December 31, 2023, including contractual options, range from two years to seven years and are subject to termination for cause provisions. The Company performs ongoing assessments of customers’ financial condition, including the consideration of customers’ ability and intention to pay, and whether all or some portion of the value of such contracts continue to meet the criteria for revenue recognition, among other factors. As of December 31, 2023, the cumulative amount of revenue recognized from Strategic Commercial Contracts was $253.9 million, of which $87.3 million of revenue was recognized during the year ended December 31, 2023. Alternative Investments During the year ended December 31, 2021, the Company purchased $50.9 million in 100-ounce gold bars. During the year ended December 31, 2023, the Company sold all of its gold bars for total proceeds of $51.1 million and recorded an immaterial realized gain within other income (expense), net in the consolidated statements of operations.

Balance Sheet Components

Balance Sheet Components	12 Months Ended
Balance Sheet Components	Dec. 31, 2023
Balance Sheet Related Disclosures [Abstract]
Balance Sheet Components	Balance Sheet Components Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): As of December 31, 2023 2022 Leasehold improvements $ 83,139 $ 80,378 Computer equipment, software, and other 50,844 52,688 Furniture and fixtures 13,834 13,010 Construction in progress 2,099 5,506 Total property and equipment, gross 149,916 151,582 Less: accumulated depreciation and amortization (102,158) (82,412) Total property and equipment, net $ 47,758 $ 69,170 Depreciation and amortization expense related to property and equipment, net was $23.7 million, $19.5 million, and $12.8 million for the years ended December 31, 2023, 2022, and 2021, respectively. Accrued Liabilities Accrued liabilities consisted of the following (in thousands): As of December 31, 2023 2022 Accrued payroll and related expenses $ 83,094 $ 43,495 Accrued taxes 47,257 41,326 Accrued other liabilities 92,640 87,894 Total accrued liabilities $ 222,991 $ 172,715

Debt

Debt	12 Months Ended
Debt	Dec. 31, 2023
Debt Disclosure [Abstract]
Debt	Debt 2014 Credit Facility In October 2014, the Company entered into an unsecured revolving credit facility, which has been subsequently secured by substantially all of the Company’s assets and amended from time to time (as amended, the “2014 Credit Facility”). As of December 31, 2023, the Company had no outstanding debt balances and had undrawn revolving commitments of $500.0 million available to fund working capital and general corporate expenditures under the 2014 Credit Facility, which has a maturity date of March 31, 2027. The 2014 Credit Facility contains customary representations and warranties, and certain financial and nonfinancial covenants, including but not limited to maintaining minimum liquidity of $50.0 million, and certain limitations on liens and indebtedness. The Company was in compliance with all covenants associated with the 2014 Credit Facility as of December 31, 2023.

Leases

Leases	12 Months Ended
Leases	Dec. 31, 2023
Leases [Abstract]
Leases	Leases The Company has operating leases primarily for corporate office space and equipment . Certain lease agreements contain renewal options, rent abatement, and escalation clauses that are factored into our determination of lease payments when appropriate. The Company's leases have remaining terms up to December 2033, some of which include one or more options to extend. Additionally, some lease contracts include termination options. Supplemental balance sheet information related to lease liabilities at December 31, 2023 and 2022 was as follows (in thousands): As of December 31, Lease-Related Assets and Liabilities Financial Statement Line Items 2023 2022 Right-of-use assets: Operating leases Operating lease right-of-use assets $ 182,863 $ 200,240 Total right-of-use assets $ 182,863 $ 200,240 Lease liabilities: Operating leases Operating lease liabilities $ 54,176 $ 45,099 Operating lease liabilities, noncurrent 175,216 204,305 Total lease liabilities $ 229,392 $ 249,404 The components of lease expense included in the Company's consolidated statements of operations include (in thousands): Years Ended December 31, 2023 2022 Operating lease expense $ 61,972 $ 55,483 Short-term lease expense 4,949 4,956 Variable lease expense 4,772 5,309 Sublease income (18,905) (13,011) Total lease expense, net $ 52,788 $ 52,737 Variable lease costs are primarily related to payments made to lessors for common area maintenance, property taxes, insurance, and other operating expenses. Short-term lease costs primarily represent temporary employee housing. Maturities of operating lease liabilities as of December 31, 2023 were as follows (in thousands): As of December 31, 2023 Operating Lease Commitments Less: Sublease Income Net Lease Commitments Year ended December 31, 2024 $ 67,420 $ 16,593 $ 50,827 2025 57,053 14,357 42,696 2026 40,068 13,748 26,320 2027 28,278 14,423 13,855 2028 21,816 12,470 9,346 Thereafter 62,116 30,761 31,355 Total undiscounted liabilities 276,751 102,352 174,399 Less: Imputed interest (47,359) — (47,359) Total operating lease liabilities $ 229,392 $ 102,352 $ 127,040 The weighted-average remaining lease term related to the Company’s operating lease liabilities as of December 31, 2023 and 2022 was six years and seven years, respectively. The weighted-average discount rate related to the Company’s operating lease liabilities as of December 31, 2023 and 2022 was 6%. The following table sets forth the supplemental information related to the Company's operating leases for the years ended December 31, 2023 and 2022 (in thousands): Years Ended December 31, 2023 2022 Cash paid for operating lease liabilities $ 63,374 $ 53,772 Lease liabilities arising from obtaining right-of-use assets $ 28,112 $ 28,169
Leases	Leases The Company has operating leases primarily for corporate office space and equipment . Certain lease agreements contain renewal options, rent abatement, and escalation clauses that are factored into our determination of lease payments when appropriate. The Company's leases have remaining terms up to December 2033, some of which include one or more options to extend. Additionally, some lease contracts include termination options. Supplemental balance sheet information related to lease liabilities at December 31, 2023 and 2022 was as follows (in thousands): As of December 31, Lease-Related Assets and Liabilities Financial Statement Line Items 2023 2022 Right-of-use assets: Operating leases Operating lease right-of-use assets $ 182,863 $ 200,240 Total right-of-use assets $ 182,863 $ 200,240 Lease liabilities: Operating leases Operating lease liabilities $ 54,176 $ 45,099 Operating lease liabilities, noncurrent 175,216 204,305 Total lease liabilities $ 229,392 $ 249,404 The components of lease expense included in the Company's consolidated statements of operations include (in thousands): Years Ended December 31, 2023 2022 Operating lease expense $ 61,972 $ 55,483 Short-term lease expense 4,949 4,956 Variable lease expense 4,772 5,309 Sublease income (18,905) (13,011) Total lease expense, net $ 52,788 $ 52,737 Variable lease costs are primarily related to payments made to lessors for common area maintenance, property taxes, insurance, and other operating expenses. Short-term lease costs primarily represent temporary employee housing. Maturities of operating lease liabilities as of December 31, 2023 were as follows (in thousands): As of December 31, 2023 Operating Lease Commitments Less: Sublease Income Net Lease Commitments Year ended December 31, 2024 $ 67,420 $ 16,593 $ 50,827 2025 57,053 14,357 42,696 2026 40,068 13,748 26,320 2027 28,278 14,423 13,855 2028 21,816 12,470 9,346 Thereafter 62,116 30,761 31,355 Total undiscounted liabilities 276,751 102,352 174,399 Less: Imputed interest (47,359) — (47,359) Total operating lease liabilities $ 229,392 $ 102,352 $ 127,040 The weighted-average remaining lease term related to the Company’s operating lease liabilities as of December 31, 2023 and 2022 was six years and seven years, respectively. The weighted-average discount rate related to the Company’s operating lease liabilities as of December 31, 2023 and 2022 was 6%. The following table sets forth the supplemental information related to the Company's operating leases for the years ended December 31, 2023 and 2022 (in thousands): Years Ended December 31, 2023 2022 Cash paid for operating lease liabilities $ 63,374 $ 53,772 Lease liabilities arising from obtaining right-of-use assets $ 28,112 $ 28,169

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Purchase Commitments In September 2023, the Company amended one of its third-party cloud hosting services agreements. Under this amendment, the Company has a commitment to spend at least $1.95 billion over ten Litigation and Legal Proceedings From time to time, third parties may assert patent infringement claims against the Company. In addition, from time to time, the Company may be subject to other legal proceedings and claims in the ordinary course of business, including claims of alleged infringement of trademarks, copyrights, and other intellectual property rights; employment claims; securities claims; investor claims; corporate claims; class action claims; and general contract, tort, or other claims. The Company may from time to time also be subject to various legal or government claims, disputes, or investigations. Such matters may include, but not be limited to, claims, disputes, allegations, or investigations related to warranty; refund; breach of contract; breach, leak, or misuse of personal data or confidential information; employment; government procurement; intellectual property; government regulation or compliance (including but not limited to anti-corruption requirements, export or other trade controls, data privacy or data protection, cybersecurity requirements, or antitrust/competition law requirements); securities; investor; corporate; or other matters. The Company establishes an accrual for loss contingencies when the loss is both probable and reasonably estimable. On September 15, 2022, October 25, 2022, and November 4, 2022, putative securities class action complaints were filed in the United States District Court for the District of Colorado, captioned Cupat v. Palantir Technologies Inc., et al., Case No. 1:22-cv-02384, Allegheny County Employees’ Retirement System v. Palantir Technologies, Inc., et al., Case No. 1:22-cv-02805, and S hijun Liu, Individually and as Trustee of the Liu Family Trust 2019 v. Palantir Technologies Inc., et al., Case No. 1:22-cv-02893, respectively, naming the Company and certain current and former officers and directors as defendants. The suits allege false and misleading statements about our business and prospects, and purport to allege claims under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Securities Act of 1933, as amended (the “Securities Act”), and seek unspecified damages and remedies under Sections 10(b), 20(a), and 20(A) of the Exchange Act and Sections 11 and 15 of the Securities Act. These three actions subsequently were consolidated as Cupat v. Palantir Technologies Inc., et al., Lead Civil Action No. 1:22-cv-02834-CNS-SKC, consolidated with civil actions 1:22-cv-02805-CNS-SKC and 1:22-cv-02893-CNS-SKC. On November 21, 2022 and January 13, 2023, stockholder derivative actions were filed in the United States District Court for the District of Colorado, captioned Li v. Karp, et al., Case No. 22-cv-3028 and Parmenter v. Karp, et al., Case No. 23-cv-118, and on January 27, 2023, a stockholder derivative action was filed in the United States District Court for the District of Delaware captioned Miao v. Karp, et al., Case No. 1:23-cv-00103-MN, each against certain current and former officers and directors asserting breach of fiduciary duty and related claims relating to the allegations of the securities class action complaints and seek unspecified damages and injunctive remedies under Section 14(a) of the Exchange Act and Delaware law. On August 22, 2023, a stockholder derivative action was filed in the Court of Chancery of the State of Delaware captioned Central Laborers’ Pension Fund v. Karp, et al. , Case No. 2023-0864 against certain current and former officers and directors asserting breach of fiduciary duty and related claims relating to the allegations of the securities class action complaints and seeks unspecified damages and injunctive relief under Delaware law. Because the litigation is in early stages, the Company is unable to estimate the reasonably possible loss or range of loss, if any, that may result from these matters. On November 20, 2023, the plaintiff in Parmenter v. Karp, et al ., Case No. 23-cv-118, filed a Notice of Voluntary Dismissal. On November 28, 2023, the court terminated the Parmenter action accordingly. As of December 31, 2023, the Company was not aware of any currently pending legal matters or claims, individually or in the aggregate, that are expected to have a material adverse impact on its consolidated financial statements. Warranties and Indemnification The Company generally provides a warranty for its software products and services and a service level agreement (“SLA”) for the Company’s performance of software operations. The Company’s products are generally warranted to perform substantially as described in the associated product documentation during the subscription term or for a period of up to 90 days where the software is hosted by the customer, and the Company includes O&M services as part of its subscription and license agreements to support this warranty and maintain the operability of the software. The Company’s services are generally warranted to be performed in a professional manner and by an adequate staff with knowledge about the products. In the event there is a failure of such warranties, the Company generally is obligated to correct the product or service to conform to the warranty provision or, if the Company is unable to do so, the customer is entitled to seek a refund of the purchase price of the product and service (generally prorated over the contract term). Due to the absence of historical warranty claims, the Company’s expectations of future claims related to products under warranty continue to be insignificant. The Company has not recorded warranty expense or related accruals as of December 31, 2023 and 2022. The Company generally agrees to indemnify its customers against legal claims that the Company’s software products infringe certain third-party intellectual property rights and accounts for its indemnification obligations. In the event of such a claim, the Company is generally obligated to defend its customer against the claim and to either settle the claim at the Company’s expense or pay damages that the customer is legally required to pay to the third-party claimant. In addition, in the event of an infringement, the Company generally agrees to secure the right for the customer to continue using the infringing product; to modify or replace the infringing product; or, if those options are not commercially practicable, to refund the cost of the software, as prorated over the period. To date, the Company has not been required to make any payment resulting from infringement claims asserted against its customers and does not believe that the Company will be liable for such claims in the foreseeable future. As such, the Company has not recorded a liability for infringement costs as of December 31, 2023 and 2022. The Company has obligations under certain circumstances to indemnify each of the defendant directors and certain officers against judgments, fines, settlements, and expenses related to claims against such directors and certain officers and otherwise to the fullest extent permitted under the law and the Company’s Amended and Restated Bylaws and Amended and Restated Certificate of Incorporation.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
Stockholders' Equity	Dec. 31, 2023
Stockholders' Equity Note [Abstract]
Stockholders' Equity	9. Stockholders’ Equity The Company’s Class A, Class B, and Class F common stock (collectively, the “common stock”) all have the same rights, except with respect to voting and conversion rights. Class A and Class B common stock have voting rights of 1 and 10 votes per share, respectively. The Class F common stock has the voting rights generally described herein and each share of Class F common stock is convertible at any time, at the option of the holder thereof, into one share of Class B common stock. All shares of Class F common stock are held in a voting trust established by Stephen Cohen, Alexander Karp, and Peter Thiel (the “Founders”). The Class F common stock generally gives the Founders the ability to control up to 49.999999% of the total voting power of the Company’s capital stock, so long as the Founders and certain of their affiliates collectively meet a minimum ownership threshold, which was 100.0 million of the Company's equity securities as of December 31, 2023. Holders of the common stock are entitled to dividends when, as, and if declared by the Company’s Board of Directors, subject to the rights of the holders of all classes of stock outstanding having priority rights to dividends. No dividends have been declared as of December 31, 2023. The following represented the total authorized, issued, and outstanding shares for each class of common stock (in thousands): As of December 31, 2023 As of December 31, 2022 Authorized Issued and Outstanding Authorized Issued and Outstanding Class A Common Stock 20,000,000 2,096,982 20,000,000 1,995,414 Class B Common Stock 2,700,000 102,141 2,700,000 102,656 Class F Common Stock 1,005 1,005 1,005 1,005 Total 22,701,005 2,200,128 22,701,005 2,099,075 Share Repurchase Program

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
Stock-Based Compensation	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation 2020 Executive Equity Incentive Plan In August 2020, the Company’s Board of Directors approved the 2020 Executive Equity Incentive Plan (the “Executive Equity Plan”). The Executive Equity Plan permitted the granting of nonstatutory stock options (“NSOs”) and RSUs to the Company’s employees, consultants, and directors. A total of 165,900,000 shares of the Company’s Class B common stock were reserved for issuance under the Executive Equity Plan. During August 2020, options to purchase 162,000,000 shares of Class B common stock and restricted stock units covering 3,900,000 shares of the Company’s Class B common stock were granted to certain officers. The Executive Equity Plan was terminated prior to the Company’s Direct Listing, and no additional awards will be granted under the Executive Equity Plan. However, the Executive Equity Plan will continue to govern the terms and conditions of the outstanding awards previously granted under the Executive Equity Plan. 2020 Equity Incentive Plan In September 2020, prior to the Direct Listing, the Company’s Board of Directors approved the 2020 Equity Incentive Plan (“2020 Plan”). The 2020 Plan provides for the grant of incentive stock options (“ISOs”), NSOs, restricted stock, RSUs, stock appreciation rights (“SARs”), and performance awards to the Company’s employees, directors, and consultants. A total of 150,000,000 shares of the Company’s Class A common stock were initially reserved for issuance pursuant to the 2020 Plan. In addition, the number of shares of Class A common stock reserved for issuance under the 2020 Plan includes certain shares of common stock subject to awards under the 2010 Equity Incentive Plan (“2010 Plan”) and Executive Equity Plan in the case of certain occurrences, such as expirations, terminations, exercise and tax-related withholding, or failures to vest. Shares of Class B common stock added to the 2020 Plan from the 2010 Plan or Executive Equity Plan are reserved for issuance under the Company’s 2020 Plan as Class A common stock. The number of shares of Class A common stock available for issuance under the 2020 Plan will also include an annual increase on the first day of each fiscal year beginning on January 1, 2022, equal to the least of: • 250,000,000 shares of the Company’s Class A common stock; • Five percent of the outstanding shares of the Company’s common stock as of the last day of the immediately preceding fiscal year; or • such other amount as the administrator of the 2020 Plan determines. Under the 2020 Plan, the exercise price of options granted is generally at least equal to the fair market value of the Company’s Class A common stock on the date of grant. The term of an ISO generally may not exceed ten years. Additionally, the exercise price of any ISO granted to a 10% stockholder shall not be less than 110% of the fair market value of the common stock on the date of grant, and the term of such option grant shall not exceed five years. Options and other equity awards become vested and, if applicable, exercisable based on terms determined by the Board of Directors or another plan administrator on the date of grant, which is typically four years for new employees and varies for subsequent grants. Stock Options The following table summarizes stock option activity for the year ended December 31, 2023 (in thousands, except per share amounts): Options Outstanding Weighted-Average Exercise Price Per Share Weighted-Average Aggregate Intrinsic Value Balance as of December 31, 2022 326,913 $ 8.05 8.33 $ 272,603 Options exercised (46,079) 4.74 Options canceled and forfeited (2,364) 5.39 Balance as of December 31, 2023 278,470 $ 8.62 7.64 $ 2,381,172 Options vested and exercisable as of December 31, 2023 160,877 $ 6.66 6.93 $ 1,691,404 The aggregate intrinsic value of options outstanding, and vested and exercisable is calculated as the difference between the exercise price of the underlying options and the fair value of the Company’s common stock as of December 31, 2023. The aggregate intrinsic value of options exercised during the years ended December 31, 2023, 2022, and 2021 was $476.8 million, $112.3 million, and $3.8 billion, respectively, and is calculated based on the difference between the exercise price and the fair value of the Company’s common stock on the exercise date. There were no options granted during the years ended December 31, 2023, 2022, and 2021. The total grant-date fair value of options that vested during the years ended December 31, 2023, 2022, and 2021 was $131.0 million, $170.8 million, and $189.5 million, respectively . As of December 31, 2023, the total unrecognized stock-based compensation expense related to options outstanding was $599.1 million, which is expected to be recognized over a weighted-average service period of seven years. RSUs and P-RSUs The following table summarizes the RSU and P-RSU activity for the year ended December 31, 2023 (in thousands, except per share amounts): RSUs P-RSUs Units Outstanding Weighted Average Grant Date Fair Value per Share Units Outstanding Weighted Average Grant Date Fair Value per Share Unvested and outstanding as of December 31, 2022 126,426 $ 10.07 — $ — Granted 19,484 11.77 1,976 15.39 Vested (54,974) 9.57 — — Canceled (8,674) 11.08 — — Unvested and outstanding as of December 31, 2023 82,262 $ 10.71 1,976 $ 15.39 During the fiscal year ended December 31, 2023, the Company granted RSUs that have only a service-based vesting condition, as well as those that have both service-based and performance-based vesting conditions (“P-RSUs”). The service-based vesting condition for each is generally satisfied upon continued service through a specified date. Vesting periods for the RSUs and P-RSUs are generally up to 4 years and three months, respectively. The performance-based vesting condition is satisfied upon the achievement of certain Company performance goals set by the Compensation Committee of the Board of Directors. The ultimate number of P-RSUs earned and eligible to vest ranges between 0% to 100% of the target number of P-RSUs granted depending on the level of achievement of such Company performance goals. The total grant-date fair value of RSUs vested during the years ended December 31, 2023, 2022, and 2021 was $526.1 million, $453.2 million, and $421.0 million, respectively. As of December 31, 2023, the total unrecognized stock-based compensation expense related to the RSUs outstanding was $566.4 million, which is expected to be recognized over a weighted-average service period of three years. As of December 31, 2023, there was no unrecognized stock-based compensation expense related to the P-RSUs outstanding. Stock-based Compensation Expense Total stock-based compensation expense was as follows (in thousands): Years Ended December 31, 2023 2022 2021 Cost of revenue $ 35,995 $ 44,061 $ 68,546 Sales and marketing 160,645 196,301 242,910 Research and development 98,064 93,871 150,298 General and administrative 181,199 230,565 316,461 Total stock-based compensation expense $ 475,903 $ 564,798 $ 778,215 The Company did not recognize any tax benefits related to stock-based compensation expense during the years ended December 31, 2023, 2022, or 2021.

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Income (loss) before provision for income taxes consisted of the following (in thousands): Years Ended December 31, 2023 2022 2021 United States $ 174,637 $ (402,834) $ (514,200) Foreign 62,454 41,807 25,706 Income (loss) before provision for income taxes $ 237,091 $ (361,027) $ (488,494) Provision for income taxes consisted of the following (in thousands): Years Ended December 31, 2023 2022 2021 Current: Federal $ — $ — $ — State 2,333 765 (88) Foreign 22,189 9,476 (11,343) Total current provision 24,522 10,241 (11,431) Deferred: Federal — — (111) State — — — Foreign (4,806) (174) 43,427 Total deferred provision (4,806) (174) 43,316 Total provision for income taxes $ 19,716 $ 10,067 $ 31,885 A reconciliation of the expected tax provision at the statutory federal income tax rate to the Company’s recorded tax provision consisted of the following (in thousands): Years Ended December 31, 2023 2022 2021 Expected tax (benefit) at U.S. federal statutory rate $ 49,789 $ (75,592) $ (102,584) State income taxes - net of federal benefit 2,309 766 (88) Foreign tax rate differential 859 832 870 Research and development tax credits (45,667) (34,546) (94,591) Stock-based compensation (79,128) 1,374 (817,839) Non-deductible officers’ compensation 34,479 40,629 428,682 Change in valuation allowance 35,070 49,833 616,572 Base Erosion Anti-Abuse Tax and related elections 14,700 25,200 — Taxes withheld at source 4,378 — — Non-deductible expenses 3,610 — — Other (683) 1,571 863 Total provision for income taxes $ 19,716 $ 10,067 $ 31,885 For the year ended December 31, 2023, the Company recorded a provision for income taxes of $19.7 million compared to $10.1 million for the year ended December 31, 2022, primarily due to the increase in foreign income taxes as the result of higher foreign taxable income and higher foreign withholding taxes in the current year. The Company maintains a full valuation allowance against its U.S. federal and state, and certain foreign deferred tax assets. For the year ended December 31, 2022, the Company recorded a provision for income taxes of $10.1 million compared to $31.9 million for the year ended December 31, 2021, primarily due to the prior year establishment of a full valuation allowance against its U.K. deferred tax assets during the fourth quarter of 2021 partially offset by permanent differences associated with U.S. Base Erosion and Anti Abuse Tax elections. The Company maintains a full valuation allowance against its U.S. federal and state and certain foreign deferred tax assets. Deferred tax assets and liabilities are recognized for the future tax consequences of differences between the carrying amounts of assets and liabilities and their respective tax basis using enacted tax rates in effect for the year in which the differences are expected to reverse. Significant deferred tax assets and liabilities consisted of the following (in thousands): As of December 31, 2023 2022 Net operating loss carryforwards $ 1,317,684 $ 1,436,957 Capitalized research and experimental expenses 214,848 70,839 Reserves and accruals 99,105 76,905 Tax credit carryforwards 277,060 226,565 Stock-based compensation 139,419 203,735 Lease liabilities 53,902 58,056 Depreciation and amortization 14,413 29,665 Capitalized facilitative expenses 28,906 — Gross deferred tax assets 2,145,337 2,102,722 Outside basis difference — (6,512) Acquisition related intangibles (8,428) (10,225) Right-of-use assets (42,721) (46,295) Total net deferred tax assets before valuation allowance 2,094,188 2,039,690 Valuation allowance (2,102,251) (2,051,655) Net deferred tax assets (liabilities) $ (8,063) $ (11,965) Because of the Company’s history of U.S. and certain foreign net operating tax losses, primarily in the U.K., the Company has maintained a full valuation allowance against potential future benefits for U.S, federal, state, and certain foreign deferred tax assets as of December 31, 2023. The valuation allowance totaled $2.1 billion for the years ended December 31, 2023 and 2022. The valuation allowance on our net deferred tax assets increased by $50.6 million and $74.1 million during the years ended December 31, 2023 and 2022, respectively. Provisions enacted by the 2017 Tax Cuts and Jobs Act related to the capitalization for tax purposes of research and experimental (“R&E”) expenditures became effective on January 1, 2022. All U.S. and foreign based R&E expenditures must be capitalized and amortized over five years and 15 years, respectively. As a result of this enactment, the Company began capitalizing and amortizing R&E expenditures over five years for domestic research and 15 for foreign research rather than expensing these costs as incurred during fiscal year ended December 31, 2022. The Company has recorded a deferred tax asset of $214.8 million as of December 31, 2023 related to the capitalization requirement. As of December 31, 2023, the Company had U.S. federal and state net operating losses of approximately $5.0 billion and $2.5 billion, respectively. As of December 31, 2022, the Company had U.S. federal and state net operating losses of approximately $5.6 billion and $2.8 billion, respectively. The U.S. federal net operating loss carryforwards will expire at various dates beginning in 2035 through 2037 if not utilized, with the exception of $4.2 billion which can be carried forward indefinitely. The state net operating loss carryforwards will expire at various dates beginning in 2025 through 2043 if not utilized. Additionally, as of December 31, 2023, the Company had federal and California research and development credits of approximately $290.1 million and $99.5 million, respectively. As of December 31, 2022, the Company had federal and California research and development credits of approximately $230.2 million and $91.4 million, respectively. The federal research and development credits will begin to expire in the years 2027 through 2043 if not utilized and the California research and development credits have no expiration date. Utilization of the net operating losses and research and development credit carryforwards may be subject to an annual limitation due to the ownership percentage change limitations provided by the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of the net operating loss and research and development credit carryforwards before utilization. As of December 31, 2023, the Company had U.S. federal capital loss carryforwards of $324.0 million. As of December 31, 2022, the Company had U.S. federal capital loss carryforwards of $113.1 million. The capital loss carryforwards will expire beginning in 2027 if not utilized. As of December 31, 2023, the Company had foreign net operating losses, primarily in the U.K., of approximately $464.7 million. These net operating losses can be carried forward indefinitely. As of December 31, 2023, the Company had an immaterial amount of earnings from its wholly-owned foreign subsidiaries indefinitely reinvested outside the U.S. The Company does not intend to repatriate these earnings and, accordingly, the Company does not provide for U.S. income taxes and foreign withholding tax on these earnings. On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on the Company’s current analysis of the provisions, the Company does not believe this legislation will have a material impact on its consolidated financial statements. Uncertain Tax Positions A reconciliation of the gross unrecognized tax benefits consists of the following (in thousands): Years Ended December 31, 2023 2022 2021 Unrecognized tax benefit beginning of year $ 81,904 $ 65,070 $ 75,557 Increases in current year tax positions 14,346 5,733 19,638 Increases in prior year tax positions 15,766 11,497 967 Decreases in prior year tax positions — (36) (30,895) Decreases in prior year tax positions due to settlements — (360) (197) Decreases in prior year tax positions due to lapse of statute of limitations — — — Unrecognized tax benefit end of year $ 112,016 $ 81,904 $ 65,070 As of December 31, 2023, 2022, and 2021, the Company recorded gross unrecognized tax benefits of $112.0 million, $81.9 million, and $65.1 million, respectively, that, if recognized, would not benefit the Company’s effective tax rate due to the valuation allowance that currently offsets deferred tax assets. As of December 31, 2023, no significant increases or decreases are expected to the Company’s uncertain tax positions within the next twelve months. It is the Company’s policy to recognize interest and penalties related to income tax matters in provision for income taxes on the consolidated statements of operations. The Company has recorded immaterial interest and penalties related to uncertain tax positions as of December 31, 2023, 2022, and 2021. The Company files U.S. federal, state, and foreign income tax returns in jurisdictions with varying statutes of limitation. The material jurisdictions where the Company is subject to potential examination by tax authorities are the U.S. (federal and state) for tax years 2004 through 2023 and the U.K. for tax years 2017 through 2023.

Net Earnings (Loss) Per Share A

Net Earnings (Loss) Per Share Attributable to Common Stockholders	12 Months Ended
	Dec. 31, 2023
Earnings Per Share [Abstract]
Net Earnings (Loss) Per Share Attributable to Common Stockholders	Net Earnings (Loss) Per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net earnings (loss) per share attributable to common stockholders (in thousands, except share and per share amounts): As of December 31, 2023 2022 2021 Numerator Net income (loss) attributable to common stockholders for diluted net earnings (loss) per share $ 209,825 $ (373,705) $ (520,379) Denominator Weighted-average shares used in computing net earnings (loss) per share: Basic 2,147,446 2,063,793 1,923,617 Effect of dilutive shares 150,481 — — Diluted 2,297,927 2,063,793 1,923,617 Net earnings (loss) per share Net earnings (loss) per share attributable to common stockholders: Basic $ 0.10 $ (0.18) $ (0.27) Diluted $ 0.09 $ (0.18) $ (0.27) The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net earnings (loss) per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands): As of December 31, 2023 2022 2021 Options and SARs issued and outstanding 162,000 326,913 349,977 RSUs and P-RSUs outstanding 13,245 126,426 153,749 Warrants to purchase common stock — 13,042 13,042 Total 175,245 466,381 516,768

Segment and Geographic Informat

Segment and Geographic Information	12 Months Ended
Segment and Geographic Information	Dec. 31, 2023
Segment Reporting [Abstract]
Segment and Geographic Information	Segment and Geographic Information The following reporting segment tables reflect the results of the Company’s reportable operating segments consistent with the manner in which the CODM evaluates the performance of each segment and allocates the Company’s resources. The CODM does not evaluate the performance of the Company’s assets on a segment basis for internal management reporting and, therefore, such information is not presented. Contribution is used, in part, to evaluate the performance of, and allocate resources to, each of the segments. A segment’s contribution is calculated as segment revenue less the related costs of revenue and sales and marketing expenses. It excludes certain operating expenses that are not allocated to segments because they are separately managed at the consolidated corporate level, or are noncash costs. These unallocated and noncash costs include stock-based compensation expense, research and development expenses, and general and administrative expenses. Financial information for each reportable segment was as follows (in thousands): Years Ended December 31, 2023 2022 2021 Revenue: Government $ 1,222,215 $ 1,071,776 $ 897,356 Commercial 1,002,797 834,095 644,533 Total revenue $ 2,225,012 $ 1,905,871 $ 1,541,889 Years Ended December 31, 2023 2022 2021 Amount % Amount % Amount % Contribution: Government $ 724,970 59 % $ 620,677 58 % $ 541,883 60 % Commercial 520,585 52 % 414,496 50 % 357,546 55 % Total contribution $ 1,245,555 56 % $ 1,035,173 54 % $ 899,429 58 % The reconciliation of contribution to income (loss) from operations is as follows (in thousands): Years Ended December 31, 2023 2022 2021 Income (loss) from operations $ 119,966 $ (161,201) $ (411,046) Research and development expenses (1) 306,560 265,808 237,189 General and administrative expenses (1) 343,126 365,768 295,071 Total stock-based compensation expense 475,903 564,798 778,215 Total contribution $ 1,245,555 $ 1,035,173 $ 899,429 ————— (1) Excludes stock-based compensation expense. Geographic Information Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages): Years Ended December 31, 2023 2022 2021 Amount % Amount % Amount % Revenue: United States $ 1,378,247 62 % $ 1,161,416 61 % $ 879,156 57 % United Kingdom 235,257 11 % 220,942 12 % 173,362 11 % Rest of world (1) 611,508 27 % 523,513 27 % 489,371 32 % Total revenue $ 2,225,012 100 % $ 1,905,871 100 % $ 1,541,889 100 % ————— (1) No other country represented 10% or more of total revenue for the years ended December 31, 2023 , 2022, or 2021 . Property and equipment, net is attributed to the Company’s office locations as follows (in thousands, except percentages): As of December 31, 2023 2022 Amount % Amount % Property and equipment, net: United States $ 28,825 60 % $ 46,599 67 % Japan 11,440 24 % 13,318 19 % United Kingdom 5,851 12 % 6,746 10 % Rest of world 1,642 4 % 2,507 4 % Total property and equipment, net $ 47,758 100 % $ 69,170 100 %

Business Combinations

Business Combinations	12 Months Ended
Business Combinations	Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combinations	Business Combinations On November 8, 2022, the Company gained the right to majority representation on the board of directors of Palantir Japan, thereby obtaining a controlling interest. Prior to obtaining a controlling interest, the Company accounted for its 50% ownership in Palantir Japan as an equity method investment, which was created to distribute Palantir platforms to the Japanese market. This transaction was accounted for as a “step acquisition” (as defined by U.S. GAAP), as such, the Company remeasured its pre-existing equity interest in Palantir Japan immediately prior to the completion of the acquisition to its estimated fair value. The results of Palantir Japan have been included in the Company’s consolidated financial statements since the acquisition date, with the portion outside of its control forming a noncontrolling interest. The fair value of Palantir Japan on the acquisition date totaled $149.0 million, which included the Company’s equity interest immediately prior to the acquisition of $74.5 million and the noncontrolling interest of $74.5 million. The amounts recognized of assets acquired and liabilities assumed as of the acquisition date included: cash of $66.7 million; goodwill of $36.1 million; intangible assets of $34.7 million related to customer relationships, reacquired rights, and backlog; $32.5 million of other identifiable assets; and $21.0 million of net liabilities. The intangible assets are reported in other assets and are being amortized over a period of two

Intangible Assets

Intangible Assets	12 Months Ended
Intangible Assets	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets Intangible assets subject to amortization that are not fully amortized are as follows (in thousands): Weighted average useful life As of December 31, 2023 As of December 31, 2022 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Customer relationships 3.83 $ 10,400 $ (2,427) $ 7,973 $ 10,400 $ (347) $ 10,053 Reacquired rights 5.83 17,618 (2,936) 14,682 17,619 (420) 17,199 Backlog 0.83 6,700 (3,908) 2,792 6,700 (558) 6,142 Other 0.27 4,225 (3,770) 455 5,717 (3,572) 2,145 Total intangible assets $ 38,943 $ (13,041) $ 25,902 $ 40,436 $ (4,897) $ 35,539 Amortization expense of intangible assets was $9.6 million and not material for the years ended December 31, 2023 and 2022, respectively. As of December 31, 2023, expected amortization expense for the unamortized finite-lived intangible assets for the next five years and thereafter is as follows (in thousands): Year ended December 31, Amount 2024 $ 7,844 2025 4,597 2026 4,597 2027 4,250 2028 2,517 Thereafter 2,097 Total $ 25,902

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Pay vs Performance Disclosure
Net Income (Loss)	$ 209,825	$ (373,705)	$ (520,379)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	12 Months Ended
Insider Trading Arrangements	Dec. 31, 2023 shares	Dec. 31, 2023 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Alexander Moore [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On November 30, 2023, Alexander Moore, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement providing for the potential sales of shares of our Class A common stock through various transactions upon the occurrence and satisfaction of certain price and/or other conditions, with 257,499 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions. The trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The duration of the trading arrangement is until February 28, 2025, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement.
Name	Alexander Moore
Title	member of our Board of Directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	November 30, 2023
Arrangement Duration	456 days
Aggregate Available	257,499	257,499
Eric Woersching [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On December 8, 2023, Eric Woersching, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement providing for the potential sales of shares of our Class A common stock through various transactions upon the occurrence and satisfaction of certain price and/or other conditions, with 35,026 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions. The trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The duration of the trading arrangement is until June 6, 2025, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement.
Name	Eric Woersching
Title	member of our Board of Directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	December 8, 2023
Arrangement Duration	546 days
Aggregate Available	35,026	35,026
David Glazer [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On December 12, 2023, David Glazer, our Chief Financial Officer and Treasurer, adopted a Rule 10b5-1 trading arrangement providing for the potential sales of shares of our Class A common stock through various transactions upon the occurrence and satisfaction of certain price and/or other conditions, with 1,479,169 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions. The trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The duration of the trading arrangement is until September 11, 2024, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement.
Name	David Glazer
Title	Chief Financial Officer and Treasurer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	December 12, 2023
Arrangement Duration	274 days
Aggregate Available	1,479,169	1,479,169
Alexander Karp [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On December 12, 2023, Alexander Karp, our Chief Executive Officer and a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement providing for the potential sales of shares of our Class A common stock through various transactions upon the occurrence and satisfaction of certain price and/or other conditions, with 48,900,000 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions, less any shares to be withheld and/or sold to satisfy applicable tax withholdings. The trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The duration of the trading arrangement is until June 1, 2025, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement.
Name	Alexander Karp
Title	Chief Executive Officer and a member of our Board of Directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	December 12, 2023
Arrangement Duration	537 days
Aggregate Available	48,900,000	48,900,000
Rivendell 7 LLC Plan [Member] \| Peter Thiel [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On December 12, 2023, Rivendell 7 LLC, a stockholder whose shares may be deemed to be beneficially owned by Peter Thiel (the Chairman of our Board of Directors), adopted a Rule 10b5-1 arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), subject to the satisfaction of certain price and/or other conditions, with 15,000,000 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions. The duration of the trading arrangement is until March 12, 2025, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement.
Name	Peter Thiel
Title	Chairman of our Board of Directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	December 12, 2023
Arrangement Duration	456 days
Aggregate Available	15,000,000	15,000,000
STS Holdings II LLC Plan [Member] \| Peter Thiel [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On December 12, 2023, STS Holdings II LLC, a stockholder whose shares may be deemed to be beneficially owned by Peter Thiel (the Chairman of our Board of Directors), adopted a Rule 10b5-1 arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), subject to the satisfaction of certain price and/or other conditions, with 5,000,000 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions. Trading under the arrangement is not authorized to begin until after all trades under the trading arrangement entered into by Rivendell 7 LLC described above are completed or expired without execution. The duration of the trading arrangement is until March 12, 2025, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement.
Name	Peter Thiel
Title	Chairman of our Board of Directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	December 12, 2023
Arrangement Duration	456 days
Aggregate Available	5,000,000	5,000,000

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
Significant Accounting Policies (Policies)	Dec. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation The accompanying consolidated financial statements have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission regarding annual financial reporting. The accompanying consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investments in entities where the Company holds at least a 20% ownership interest and has the ability to exercise significant influence over, but does not control, the investee are accounted for using the equity method of accounting. Certain prior year balances have been reclassified to conform to the current year presentation. Such reclassifications did not affect total revenues, income (loss) from operations, net income (loss), or cash flows. The Company’s fiscal year ends on December 31.
Use of Estimates	Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions made in the accompanying consolidated financial statements include, but are not limited to, the identification of performance obligations in customer contracts, the valuation of deferred tax assets and uncertain tax positions, and the collectability of contract consideration, including accounts receivable. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations.
Segments	Segments The Company has two operating segments, commercial and government, which were determined based on the manner in which the chief operating decision maker (“CODM”), who is the Chief Executive Officer, manages the operations of the Company for purposes of allocating resources and evaluating performance. Various factors, including the Company’s organizational and management reporting structure and customer type, were considered in determining these operating segments. The Company’s operating segments are described below: • Commercial: This segment primarily serves customers working in non-government industries. • Government: This segment primarily serves customers that are United States (“U.S.”) government and non-U.S. government agencies.
Cash, Cash Equivalents, and Restricted Cash	Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of amounts invested in money market funds and available-for-sale debt securities. Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the amounts shown in the consolidated statements of cash flows (in thousands): As of December 31, 2023 2022 2021 Cash and cash equivalents $ 831,047 $ 2,598,540 $ 2,290,674 Restricted cash included in prepaid expenses and other current assets 370 16,244 36,628 Restricted cash included in other assets 18,690 12,551 39,612 Total cash, cash equivalents, and restricted cash $ 850,107 $ 2,627,335 $ 2,366,914
Accounts Receivable and Allowance for Credit Losses	Accounts Receivable and Allowance for Credit Losses Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. The Company generally grants non-collateralized credit terms to its customers. Allowance for credit losses is based on the Company’s best estimate of probable losses inherent in its accounts receivable portfolio and is determined based on expectations of the customer’s ability to pay by considering factors such as customer type (commercial or government), historical experience, financial position of the customer, age of the accounts receivable, current economic conditions, and reasonable and supportable forward-looking factors about its portfolio and future economic conditions. Accounts receivable are written-off and charged against an allowance for credit losses when the Company has exhausted collection efforts without success. Based upon the Company’s assessment as of December 31, 2023 and 2022, the Company recorded an allowance for credit losses of $10.5 million and $10.1 million, respectively.
Debt Securities	Debt Securities Debt securities are primarily comprised of U.S. treasury securities. The debt securities are classified as available-for-sale at the time of purchase and are reevaluated as of each balance sheet date. The Company considers the majority of its available-for-sale debt securities as available for use in current operations and may sell these securities at any time, and therefore classifies these securities as current assets in its consolidated balance sheets. Debt securities included in marketable securities on the consolidated balance sheets consist of U.S. treasury securities with original maturities of greater than three months at the time of purchase, and the remaining U.S. treasury securities are included in cash and cash equivalents. Interest income on debt securities is included in other income (expense), net on the consolidated statements of operations. The majority of the Company’s available-for-sale securities are recorded at fair value each reporting period using quoted prices of similar instruments and are classified within Level 2 of the fair value hierarchy. The Company evaluates investments with unrealized loss positions for other than temporary impairment by assessing if they are related to deterioration in credit risk and whether it expects to recover the entire amortized cost basis of the security, the Company’s intent to sell, and whether it is more likely than not that the Company will be required to sell the securities before the recovery of their cost basis. Credit-related impairment losses, not to exceed the amount that fair value is less than the amortized cost basis, are recognized in other income (expense), net in the consolidated statements of operations. Unrealized gains and non-credit related losses are reported as a separate component of accumulated other comprehensive loss, net in the consolidated balance sheets until realized. Realized gains and losses and declines in value judged to be other than temporary are determined based on the specific identification method and are reported in other income (expense), net in the consolidated statements of operations.
Concentrations of Credit Risk	Concentrations of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, accounts receivable, marketable securities, and privately-held equity securities. Cash equivalents primarily consist of money market funds and U.S. treasury securities with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts. The Company is exposed to concentrations of credit risk with respect to accounts receivable presented in the consolidated balance sheets. The Company’s accounts receivable balances as of December 31, 2023 and 2022 were $364.8 million and $258.3 million, respectively. Customer I represented 15% of total accounts receivable as of December 31, 2023, and no other customer represented more than 10% of total accounts receivable as of December 31, 2023. No customer represented more than 10% of total accounts receivable as of December 31, 2022. For the years ended December 31, 2023, 2022, and 2021, no customer represented 10% or more of total revenue.
Alternative Investments	Alternative Investments Alternative investments include gold bars and are recorded in prepaid expenses and other current assets on the consolidated balance sheets. The investments are initially recorded at cost and subsequently remeasured at the lower of cost or market each reporting period. Market value is determined by using quoted market prices of identical or similar assets from active markets. Unrealized losses are recorded in other income (expense), net in the consolidated statements of operations. Realized gains and losses are recorded in other income (expense), net upon realization.
Property and Equipment, Net	Property and Equipment, Net Property and equipment, net are stated at cost less accumulated depreciation and amortization. Depreciation is recognized using the straight-line method over the estimated useful lives of the respective assets, which are generally three years. Leasehold improvements are capitalized and amortized using the straight-line method over the shorter of the remaining lease term or the estimated useful life, which is generally five years. Maintenance and repairs that do not improve or extend the useful lives of the assets are expensed when incurred. Upon sale or retirement of assets, the cost and related accumulated depreciation and amortization are derecognized from the consolidated balance sheets and any resulting gain or loss is recorded in the consolidated statements of operations in the period realized.
Privately-held Equity Securities	Privately-held Equity Securities Equity securities in privately-held companies without readily determinable fair values are recorded using the measurement alternative. Such investments are carried at cost, less any impairments, and are adjusted for subsequent observable price changes in orderly transactions for identical or similar investments of the same issuer. Changes in the basis of the equity securities are recognized in other income (expense), net in the consolidated statements of operations.
Business Combinations	Business Combinations Business combinations are accounted for using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) 805, Business Combinations, and are included in our consolidated financial statements from their respective acquisition dates. Assets acquired and liabilities assumed, if any, are measured at fair value on the acquisition date using the appropriate valuation method. Goodwill generated from acquisitions is recognized if the fair value of the purchase consideration transferred, or the fair value of the acquirer’s interest in the acquiree if no consideration is transferred, and any noncontrolling interests is in excess of the net fair value of the identifiable assets acquired and the liabilities assumed. In determining the fair value of identifiable assets, we use various valuation techniques which require us to make estimates and assumptions surrounding projected revenues and costs, future growth, and discount rates.
Goodwill	Goodwill Goodwill represents the excess of the fair value of the purchase consideration transferred, or the fair value of the acquirer’s interest in the acquiree if no consideration is transferred, and any noncontrolling interests over the net fair value of the identifiable assets acquired and the liabilities assumed in business combinations. Goodwill is not amortized but is subject to an annual impairment test. We perform our annual goodwill impairment assessment on the first day of the fourth quarter. Tests are performed more frequently if events occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Goodwill is recorded in other assets in the consolidated balance sheet.
Other Intangible Assets	Other Intangible Assets
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment annually or whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability is measured by comparing the carrying amount of an asset to the future undiscounted cash flows that the asset is expected to generate. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Impairments of long-lived assets during the years ended December 31, 2023, 2022, and 2021 were not material.
Leases	Leases The Company determines if an arrangement is a lease at inception. An arrangement is or contains a lease if it conveys the right to control the use of an identified asset for a period of time in exchange for consideration. If a lease is identified, classification is determined at lease commencement. Operating lease liabilities are recognized at the present value of the future lease payments at the lease commencement date. The Company’s leases do not provide an implicit interest rate and therefore the Company estimates its incremental borrowing rate to discount lease payments. The incremental borrowing rate reflects the interest rate that the Company would have to pay to borrow on a collateralized basis an amount equal to the lease payments in a similar economic environment over a similar term. Operating lease right-of-use (“ROU”) assets are based on the corresponding lease liability adjusted for any lease payments made at or before commencement, initial direct costs, and lease incentives. Renewals or early terminations are not accounted for unless the Company is reasonably certain to exercise these options. Operating lease expense is recognized and the ROU asset is amortized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component. For short-term leases, defined as leases with a term of twelve months or less, the Company elected the practical expedient to not recognize an associated lease liability and ROU asset. Lease payments for short-term leases are expensed on a straight-line basis over the lease term. Operating leases are included in operating lease right-of-use assets, operating lease liabilities, and operating lease liabilities, non-current
Fair Value Measurement	Fair Value Measurement Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, or an exit price, in the principal or most advantageous market for that asset or liability in an orderly transaction between market participants on the measurement date. The Company measures fair value based on a three-level hierarchy of inputs, maximizing the use of observable inputs, where available, and minimizing the use of unobservable inputs when measuring fair value. A financial instrument’s level within the three-level hierarchy is based on the lowest level of input that is significant to the fair value measurement. The three-level hierarchy of inputs is as follows: Level 1: Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. These inputs are based on the Company’s own assumptions about current market conditions and require significant management judgment or estimation. Financial instruments consist of money market funds and certificates of deposit included in cash equivalents and restricted cash, accounts receivable, marketable securities, other assets accounted for at fair value, accounts payable, and accrued liabilities. Money market funds, certificates of deposit, and marketable securities are stated at fair value on a recurring basis. Accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date.
Revenue Recognition	Revenue Recognition The Company generates revenue from the sale of subscriptions to access its software platforms in the Company’s hosted environment, along with ongoing operations and maintenance (“O&M”) services (“Palantir Cloud”); software licenses, primarily term licenses in the customers’ environments, with ongoing O&M services (“On-Premises Software”); and professional services. In accordance with ASC 606, Revenue from Contracts with Customers , the Company recognizes revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company applies the following five-step revenue recognition model in accounting for its revenue arrangements: • Identification of the contract(s) with the customer, including whether collectability of the consideration is probable by considering the customers’ ability and intention to pay; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, the Company satisfies a performance obligation. Additionally, the pricing of the Company’s contracts is generally fixed; however, it is possible for contracts to include variable consideration, which can be based on subjective or objective criteria. The Company includes the estimated amount of variable consideration that it expects to receive to the extent it is probable that a significant revenue reversal will not occur. Each of the Company’s significant performance obligations and the Company’s application of ASC 606 to its revenue arrangements is discussed in further detail below. Palantir Cloud The Company’s Palantir Cloud subscriptions grant customers the right to access the software functionality in a hosted environment controlled by Palantir and are sold together with stand-ready O&M services, as further described below. The Company agrees to provide continuous access to its hosted software platforms throughout the contract term. Revenue associated with Palantir Cloud subscriptions is generally recognized over the contract term on a ratable basis, which is consistent with the transfer of control of the Palantir Cloud subscription to the customer. On-Premises Software Sales of the Company’s software licenses, primarily term licenses, grant customers the right to use functional intellectual property, either on their internal hardware infrastructure or on their own cloud instance, over the contractual term and are also sold together with stand-ready O&M services. The O&M services include critical updates, support, and maintenance services required to operate the software and, as such, are necessary for the software to maintain its intended utility over the contractual term. Because of this requirement, the Company has concluded that the software licenses and O&M services, which together the Company refers to as On-Premises Software, are highly interdependent and interrelated and represent a single distinct performance obligation within the context of the contract. Revenue is generally recognized over the contract term on a ratable basis. Professional Services The Company’s professional services support the customers’ use of the software platforms and include, as needed, on-demand user support, user-interface configuration, training, and ongoing ontology and data modeling support. Professional services contracts typically include the provision of on-demand professional services for the duration of the contractual term. These services are typically coterminous with a Palantir Cloud subscription or the On-Premises Software. Professional services are on-demand, whereby the Company performs services throughout the contract period; therefore, the revenue is recognized over the contractual term. Contract Liabilities The timing of customer billings and payments relative to the start of the service period varies from contract to contract; however, the Company bills many of its customers in advance of the provision of services under its contracts, resulting in contract liabilities consisting of either deferred revenue or customer deposits (“contract liabilities”). Deferred revenue represents billings under noncancelable contracts before the related product or service is transferred to the customer. Customer deposits consist of amounts billed and/or paid in advance of the start of the contractual term or for anticipated revenue generating activities for the portion of a contract term that is subject to cancellation by its customers. Many of the Company’s arrangements include terms that allow the customer to terminate the contract for convenience and receive a pro-rata refund of the amount of the customer deposit for the period of time remaining in the contract term after the applicable termination notice period expires. In these arrangements, the Company concluded there are no enforceable rights and obligations after such notice period and therefore the consideration received or due from the customer that is subject to termination for convenience is recorded as customer deposits. The payment terms and conditions vary by contract; however, the Company’s terms generally require payment within 30 to 60 days from the invoice date. In instances where the timing of revenue recognition differs from the timing of payment, the Company elected to apply the practical expedient in accordance with ASC 606 to not adjust contract consideration for the effects of a significant financing component as the Company expects, at contract inception, that the period between when promised goods and services are transferred to the customer and when the customer pays for those goods and services will be one year or less. As such, the Company determined its contracts do not generally contain a significant financing component. Areas of Judgment and Estimation The Company’s contracts with customers can include multiple promises to transfer goods or services to the customer. Determining whether promises are distinct performance obligations that should be accounted for separately – or not distinct within the context of the contract and, thus, accounted for together – requires significant judgment. The Company concluded that the promise to provide a software license is highly interdependent and interrelated with the promise to provide O&M services and such promises are not distinct within the context of its contracts and are accounted for as a single performance obligation as the Company’s On-Premises Software. Significant estimates and assumptions are used in the identification of performance obligations in customer contracts and collectability of contract consideration, including accounts receivable. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect our financial position and results of operations. Costs to Obtain and Fulfill Contracts Incremental costs of obtaining a contract include only those costs that are directly related to the acquisition of contracts, including sales commissions, and that would not have been incurred if the contract had not been obtained. The Company recognizes a contract cost asset for the incremental costs of obtaining a contract with a customer if it is expected that the economic benefit and amortization period will be longer than one year. Costs to obtain contracts were not material in the periods presented. The Company recognizes an asset for the costs to fulfill a contract with a customer if the costs are specifically identifiable, generate or enhance resources used to satisfy future performance obligations, and are expected to be recovered. Costs to fulfill contracts were not material in the periods presented.
Software Development Costs	Software Development Costs The Company evaluates capitalization of certain software development costs subsequent to the establishment of technological feasibility. Based on the Company’s product development process and substantial development risks, technological feasibility is generally established for the Company’s products when they are made available for general release. Accordingly, most costs are charged to research and development expense in the period incurred.
Cost of Revenue	Cost of Revenue
Sales and Marketing Costs	Sales and Marketing Costs Sales and marketing costs primarily include salaries, stock-based compensation expense, commissions, and benefits for the sales force and personnel involved in sales functions, executing on pilots, including bootcamps, and performing other brand building and customer growth activities, as well as third-party cloud hosting services for pilots, marketing and sales event-related costs, travel costs, and allocated overhead. The Company generally charges all such costs to sales and marketing expense in the period incurred. Advertising costs are expensed as incurred and included in sales and marketing expense within the consolidated statements of operations. Advertising expense totaled $21.4 million, $38.6 million, and $26.3 million for the years ended December 31, 2023, 2022, and 2021, respectively.
Research and Development Costs	Research and Development Costs
Commitments and Contingencies	Commitments and Contingencies
Stock-Based Compensation	Stock-Based Compensation The Company accounts for stock-based compensation expense in accordance with the fair value recognition and measurement provisions of GAAP, which require compensation cost for the grant-date fair value of stock-based awards to be recognized over the requisite service period. The Company determines the fair value of stock-based awards granted or modified on the grant date or modification date using appropriate valuation techniques. The Company recognizes forfeitures as they occur. Service-Based Vesting The Company grants RSUs and stock option awards that vest based upon the satisfaction of only a service condition. For RSUs, the Company determines the grant-date fair value of the RSUs as the fair value of the Company’s common stock on the grant date. The Company records stock-based compensation expense for stock options and RSUs that vest based upon the satisfaction of only a service condition on a straight-line basis over the requisite service period, which is generally one Performance-Based Vesting The Company also grants awards, including RSUs, that vest upon the satisfaction of both a service condition and a performance condition. The Company determines the grant-date fair value of RSUs with both a service-based vesting condition and a performance-based vesting condition as the fair value of the Company’s common stock on the grant date and records stock-based compensation expense using the accelerated attribution method over the service period. The performance-based vesting condition for the RSUs granted prior to September 30, 2020, the date the Company completed a direct listing of its Class A common stock on the New York Stock Exchange (the “Direct Listing”) was satisfied upon the occurrence of the Company’s Direct Listing. For performance-based RSUs granted after the Direct Listing (“P-RSUs”), the Company recognizes expense from the number of P-RSUs expected to vest, determined based on the level of achievement against certain performance conditions, over the requisite service period when it is probable that the performance condition will be achieved. The probability of achievement is assessed periodically to determine whether the performance metric continues to be probable. When there is a change in the assessment of the probability of achievement, any cumulative effect of the change is recognized in the period of the change and any remaining expense of the related awards is amortized over the remaining service period.
Employee Benefit Plan	Employee Benefit Plan The Company sponsors a 401(k) tax-deferred savings plan for all employees who meet certain eligibility requirements. Participants may contribute, on a pretax and post-tax basis, a percentage of their qualifying annual compensation, but not to exceed a maximum contribution amount pursuant to Section 401(k) of the Internal Revenue Code. The Company may make additional matching contributions on behalf of the participants. The Company did not make matching contributions for the years ended December 31, 2023, 2022, and 2021.
Income Taxes	Income Taxes The Company estimates its current tax expense together with assessing temporary differences resulting from differing treatment of items not currently deductible for tax purposes. These differences result in deferred tax assets and liabilities on the Company’s consolidated balance sheets, which are estimated based upon the difference between the financial statement and tax bases of assets and liabilities using the enacted tax rates that will be in effect when these differences reverse. In general, deferred tax assets represent future tax benefits to be received when certain expenses previously recognized in the Company’s consolidated statements of operations become deductible expenses under applicable income tax laws or loss or credit carryforwards are utilized. Accordingly, the realization of the Company’s deferred tax assets is dependent on future taxable income against which these deductions, losses, and credits can be utilized. The Company evaluates the realizability of its deferred tax assets and recognizes a valuation allowance when it is more likely than not that a future benefit on such deferred tax assets will not be realized. The Company considers all evidence, both positive and negative, in determining any required valuation allowance and evaluates the need for a valuation allowance on a regular basis. The Company performs an assessment of both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. Such assessment is required on a jurisdiction by jurisdiction basis. The Company reviews the recognition of deferred tax assets on a regular basis to determine if realization of such assets is more likely than not. A valuation allowance is provided when it is more likely than not that such assets will not be realized. If certain factors change and the Company determines that the deferred tax assets are realizable at a more-likely-than not level, it will adjust the valuation allowance in the period the determination is made. Changes in the valuation allowance, when recorded, would be included in the Company’s consolidated statements of operations. Management’s judgment is required in determining the Company’s valuation allowance recorded against its net deferred tax assets. The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. The Company recognizes interest and penalties related to uncertain tax positions in its provision for income taxes. The Company is subject to the Global Intangible Low Taxed Income (“GILTI”) tax in the U.S. and has elected to treat taxes on future GILTI inclusions as current period expense if and when incurred.
Net Earnings (Loss) Per Share Attributable to Common Stockholders	Net Earnings (Loss) Per Share Attributable to Common Stockholders The Company computes net earnings (loss) per share attributable to its common stockholders using the two-class method required for participating securities, which determines net earnings (loss) per common share for each class of common stock and participating securities according to dividends declared or accumulated and participation rights in distributed and undistributed earnings. The two-class method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The rights, including the liquidation and dividend rights, of the holders of Class A, Class B, and Class F common stock (collectively, the “common stock”) are identical, except with respect to voting and conversion. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting net earnings (loss) per share will, therefore, be the same for all classes of common stock on an individual or comb ined basis. As such, the Company has presented the net income (loss) attributed to its common stock on a combined basis.
Noncontrolling Interests	Noncontrolling Interests A noncontrolling interest represents the proportionate equity interest in a subsidiary that is not attributable, either directly or indirectly, to the Company and is reported as equity of the Company, separate from the Company’s controlling interest. Revenues, expenses, gains, losses, net income (loss), and other comprehensive income (loss) are reported in the consolidated financial statements at the consolidated amounts, which include the amounts attributable to both the controlling and noncontrolling interest.
Foreign Currency	Foreign Currency Generally, the functional currency of the Company’s international subsidiaries is the local currency of the country in which they operate. The Company translates the assets and liabilities of its non-U.S. dollar functional currency subsidiaries into U.S. dollars using exchange rates in effect at the end of each reporting period. Revenue and expenses for these subsidiaries are translated using rates that approximate those in effect during the period. Gains and losses from these translations are recognized as a cumulative translation adjustment and included in accumulated other comprehensive income (loss). For transactions that are not denominated in the local functional currency, the Company remeasures monetary assets and liabilities at exchange rates in effect at the end of each reporting period. Transaction gains and losses from the remeasurement are recognized in other income (expense), net within the consolidated statements of operations.
Recent Accounting Pronouncements Not Yet Adopted	Recent Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which requires disclosure of incremental segment information on an annual and interim basis. This standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective application to all prior periods presented in the financial statements. The Company is currently evaluating the impacts of the new standard. In December 2023, the FASB issued ASU 2023-09, Income Taxes – Improvements to Income Tax Disclosures , requiring enhancements and further transparency to certain income tax disclosures, most notably the tax rate reconciliation and income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024 on a prospective basis and retrospective application is permitted. The Company is currently evaluating the impacts of the new standard.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	12 Months Ended
Significant Accounting Policies (Tables)	Dec. 31, 2023
Accounting Policies [Abstract]
Schedule of Cash and Cash Equivalents	The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the amounts shown in the consolidated statements of cash flows (in thousands): As of December 31, 2023 2022 2021 Cash and cash equivalents $ 831,047 $ 2,598,540 $ 2,290,674 Restricted cash included in prepaid expenses and other current assets 370 16,244 36,628 Restricted cash included in other assets 18,690 12,551 39,612 Total cash, cash equivalents, and restricted cash $ 850,107 $ 2,627,335 $ 2,366,914

Investments and Fair Value Me_2

Investments and Fair Value Measurements (Tables)	12 Months Ended
Investments and Fair Value Measurements (Tables)	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Summary Of Assets and Liabilities that are Measured at Fair Value on a Recurring and Nonrecurring Basis	The following tables present the Company’s assets that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation (in thousands): As of December 31, 2023 Total Level 1 Level 2 Level 3 Assets: Cash and cash equivalents: Money market funds $ 576,565 $ 576,565 $ — $ — U.S. treasury securities 10,079 — 10,079 — Certificates of deposit 938 — 938 — Prepaid expenses and other current assets and other assets: Certificates of deposit 4,777 — 4,777 — Marketable securities: U.S. treasury securities 2,824,861 — 2,824,861 — Publicly-traded equity securities 18,271 18,271 — — Total $ 3,435,491 $ 594,836 $ 2,840,655 $ — As of December 31, 2022 Total Level 1 Level 2 Level 3 Assets: Cash and cash equivalents: Money market funds $ 1,149,302 $ 1,149,302 $ — $ — Certificates of deposit 6,791 — 6,791 — Prepaid expenses and other current assets and other assets: Certificates of deposit 18,707 — 18,707 — Marketable securities: Publicly-traded equity securities 35,135 35,135 — — Total $ 1,209,935 $ 1,184,437 $ 25,498 $ —
Debt Securities, Available-for-Sale	As of December 31, 2023, available-for-sale debt securities consisted of the following (in thousands): As of December 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 2,831,505 $ 4,520 $ (1,085) $ 2,834,940 Total debt securities $ 2,831,505 $ 4,520 $ (1,085) $ 2,834,940 Included in cash and cash equivalents $ 10,078 $ 1 $ — $ 10,079 Included in marketable securities $ 2,821,427 $ 4,519 $ (1,085) $ 2,824,861

Balance Sheet Components (Table

Balance Sheet Components (Tables)	12 Months Ended
Balance Sheet Components (Tables)	Dec. 31, 2023
Balance Sheet Related Disclosures [Abstract]
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following (in thousands): As of December 31, 2023 2022 Leasehold improvements $ 83,139 $ 80,378 Computer equipment, software, and other 50,844 52,688 Furniture and fixtures 13,834 13,010 Construction in progress 2,099 5,506 Total property and equipment, gross 149,916 151,582 Less: accumulated depreciation and amortization (102,158) (82,412) Total property and equipment, net $ 47,758 $ 69,170
Schedule of Accrued Liabilities	Accrued liabilities consisted of the following (in thousands): As of December 31, 2023 2022 Accrued payroll and related expenses $ 83,094 $ 43,495 Accrued taxes 47,257 41,326 Accrued other liabilities 92,640 87,894 Total accrued liabilities $ 222,991 $ 172,715

Leases (Tables)

Leases (Tables)	12 Months Ended
Leases (Tables)	Dec. 31, 2023
Leases [Abstract]
Supplemental Balance Sheet Information Related To Lease Liabilities and Components of Lease Expense	Supplemental balance sheet information related to lease liabilities at December 31, 2023 and 2022 was as follows (in thousands): As of December 31, Lease-Related Assets and Liabilities Financial Statement Line Items 2023 2022 Right-of-use assets: Operating leases Operating lease right-of-use assets $ 182,863 $ 200,240 Total right-of-use assets $ 182,863 $ 200,240 Lease liabilities: Operating leases Operating lease liabilities $ 54,176 $ 45,099 Operating lease liabilities, noncurrent 175,216 204,305 Total lease liabilities $ 229,392 $ 249,404 The components of lease expense included in the Company's consolidated statements of operations include (in thousands): Years Ended December 31, 2023 2022 Operating lease expense $ 61,972 $ 55,483 Short-term lease expense 4,949 4,956 Variable lease expense 4,772 5,309 Sublease income (18,905) (13,011) Total lease expense, net $ 52,788 $ 52,737 The following table sets forth the supplemental information related to the Company's operating leases for the years ended December 31, 2023 and 2022 (in thousands): Years Ended December 31, 2023 2022 Cash paid for operating lease liabilities $ 63,374 $ 53,772 Lease liabilities arising from obtaining right-of-use assets $ 28,112 $ 28,169
Maturities of Operating Lease Liabilities	Maturities of operating lease liabilities as of December 31, 2023 were as follows (in thousands): As of December 31, 2023 Operating Lease Commitments Less: Sublease Income Net Lease Commitments Year ended December 31, 2024 $ 67,420 $ 16,593 $ 50,827 2025 57,053 14,357 42,696 2026 40,068 13,748 26,320 2027 28,278 14,423 13,855 2028 21,816 12,470 9,346 Thereafter 62,116 30,761 31,355 Total undiscounted liabilities 276,751 102,352 174,399 Less: Imputed interest (47,359) — (47,359) Total operating lease liabilities $ 229,392 $ 102,352 $ 127,040

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
Stockholders' Equity (Tables)	Dec. 31, 2023
Stockholders' Equity Note [Abstract]
Summary of Total Authorized, Issued, And Outstanding Shares	The following represented the total authorized, issued, and outstanding shares for each class of common stock (in thousands): As of December 31, 2023 As of December 31, 2022 Authorized Issued and Outstanding Authorized Issued and Outstanding Class A Common Stock 20,000,000 2,096,982 20,000,000 1,995,414 Class B Common Stock 2,700,000 102,141 2,700,000 102,656 Class F Common Stock 1,005 1,005 1,005 1,005 Total 22,701,005 2,200,128 22,701,005 2,099,075

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
Stock-Based Compensation (Tables)	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Summary of Stock Option Activity	The following table summarizes stock option activity for the year ended December 31, 2023 (in thousands, except per share amounts): Options Outstanding Weighted-Average Exercise Price Per Share Weighted-Average Aggregate Intrinsic Value Balance as of December 31, 2022 326,913 $ 8.05 8.33 $ 272,603 Options exercised (46,079) 4.74 Options canceled and forfeited (2,364) 5.39 Balance as of December 31, 2023 278,470 $ 8.62 7.64 $ 2,381,172 Options vested and exercisable as of December 31, 2023 160,877 $ 6.66 6.93 $ 1,691,404
Summary of RSU Activity	The following table summarizes the RSU and P-RSU activity for the year ended December 31, 2023 (in thousands, except per share amounts): RSUs P-RSUs Units Outstanding Weighted Average Grant Date Fair Value per Share Units Outstanding Weighted Average Grant Date Fair Value per Share Unvested and outstanding as of December 31, 2022 126,426 $ 10.07 — $ — Granted 19,484 11.77 1,976 15.39 Vested (54,974) 9.57 — — Canceled (8,674) 11.08 — — Unvested and outstanding as of December 31, 2023 82,262 $ 10.71 1,976 $ 15.39
Summary of Stock-Based Compensation Expense	Total stock-based compensation expense was as follows (in thousands): Years Ended December 31, 2023 2022 2021 Cost of revenue $ 35,995 $ 44,061 $ 68,546 Sales and marketing 160,645 196,301 242,910 Research and development 98,064 93,871 150,298 General and administrative 181,199 230,565 316,461 Total stock-based compensation expense $ 475,903 $ 564,798 $ 778,215

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Summary of Loss Before Provision for (benefit from) Income Taxes	Income (loss) before provision for income taxes consisted of the following (in thousands): Years Ended December 31, 2023 2022 2021 United States $ 174,637 $ (402,834) $ (514,200) Foreign 62,454 41,807 25,706 Income (loss) before provision for income taxes $ 237,091 $ (361,027) $ (488,494)
Summary of Provision for (benefit from) Income Taxes	Provision for income taxes consisted of the following (in thousands): Years Ended December 31, 2023 2022 2021 Current: Federal $ — $ — $ — State 2,333 765 (88) Foreign 22,189 9,476 (11,343) Total current provision 24,522 10,241 (11,431) Deferred: Federal — — (111) State — — — Foreign (4,806) (174) 43,427 Total deferred provision (4,806) (174) 43,316 Total provision for income taxes $ 19,716 $ 10,067 $ 31,885
Summary of Reconciliation of Effective Income Tax Rate	A reconciliation of the expected tax provision at the statutory federal income tax rate to the Company’s recorded tax provision consisted of the following (in thousands): Years Ended December 31, 2023 2022 2021 Expected tax (benefit) at U.S. federal statutory rate $ 49,789 $ (75,592) $ (102,584) State income taxes - net of federal benefit 2,309 766 (88) Foreign tax rate differential 859 832 870 Research and development tax credits (45,667) (34,546) (94,591) Stock-based compensation (79,128) 1,374 (817,839) Non-deductible officers’ compensation 34,479 40,629 428,682 Change in valuation allowance 35,070 49,833 616,572 Base Erosion Anti-Abuse Tax and related elections 14,700 25,200 — Taxes withheld at source 4,378 — — Non-deductible expenses 3,610 — — Other (683) 1,571 863 Total provision for income taxes $ 19,716 $ 10,067 $ 31,885
Summary of Significant Deferred Tax Assets and Liabilities	Significant deferred tax assets and liabilities consisted of the following (in thousands): As of December 31, 2023 2022 Net operating loss carryforwards $ 1,317,684 $ 1,436,957 Capitalized research and experimental expenses 214,848 70,839 Reserves and accruals 99,105 76,905 Tax credit carryforwards 277,060 226,565 Stock-based compensation 139,419 203,735 Lease liabilities 53,902 58,056 Depreciation and amortization 14,413 29,665 Capitalized facilitative expenses 28,906 — Gross deferred tax assets 2,145,337 2,102,722 Outside basis difference — (6,512) Acquisition related intangibles (8,428) (10,225) Right-of-use assets (42,721) (46,295) Total net deferred tax assets before valuation allowance 2,094,188 2,039,690 Valuation allowance (2,102,251) (2,051,655) Net deferred tax assets (liabilities) $ (8,063) $ (11,965)
Summary of Reconciliation of the Gross Unrecognized Tax Benefits	A reconciliation of the gross unrecognized tax benefits consists of the following (in thousands): Years Ended December 31, 2023 2022 2021 Unrecognized tax benefit beginning of year $ 81,904 $ 65,070 $ 75,557 Increases in current year tax positions 14,346 5,733 19,638 Increases in prior year tax positions 15,766 11,497 967 Decreases in prior year tax positions — (36) (30,895) Decreases in prior year tax positions due to settlements — (360) (197) Decreases in prior year tax positions due to lapse of statute of limitations — — — Unrecognized tax benefit end of year $ 112,016 $ 81,904 $ 65,070

Net Earnings (Loss) Per Share_2

Net Earnings (Loss) Per Share Attributable to Common Stockholders (Tables)	12 Months Ended
	Dec. 31, 2023
Earnings Per Share [Abstract]
Summary of Calculation of Basic and Diluted Net Loss Per Share	The following table presents the calculation of basic and diluted net earnings (loss) per share attributable to common stockholders (in thousands, except share and per share amounts): As of December 31, 2023 2022 2021 Numerator Net income (loss) attributable to common stockholders for diluted net earnings (loss) per share $ 209,825 $ (373,705) $ (520,379) Denominator Weighted-average shares used in computing net earnings (loss) per share: Basic 2,147,446 2,063,793 1,923,617 Effect of dilutive shares 150,481 — — Diluted 2,297,927 2,063,793 1,923,617 Net earnings (loss) per share Net earnings (loss) per share attributable to common stockholders: Basic $ 0.10 $ (0.18) $ (0.27) Diluted $ 0.09 $ (0.18) $ (0.27)
Summary of Antidilutive Securities	The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net earnings (loss) per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands): As of December 31, 2023 2022 2021 Options and SARs issued and outstanding 162,000 326,913 349,977 RSUs and P-RSUs outstanding 13,245 126,426 153,749 Warrants to purchase common stock — 13,042 13,042 Total 175,245 466,381 516,768

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	12 Months Ended
Segment and Geographic Information (Tables)	Dec. 31, 2023
Segment Reporting [Abstract]
Summary of Financial Information for Each Reportable Segment	Financial information for each reportable segment was as follows (in thousands): Years Ended December 31, 2023 2022 2021 Revenue: Government $ 1,222,215 $ 1,071,776 $ 897,356 Commercial 1,002,797 834,095 644,533 Total revenue $ 2,225,012 $ 1,905,871 $ 1,541,889 Years Ended December 31, 2023 2022 2021 Amount % Amount % Amount % Contribution: Government $ 724,970 59 % $ 620,677 58 % $ 541,883 60 % Commercial 520,585 52 % 414,496 50 % 357,546 55 % Total contribution $ 1,245,555 56 % $ 1,035,173 54 % $ 899,429 58 %
Summary of Reconciliation of Segment Financial Information to Loss from Operations	The reconciliation of contribution to income (loss) from operations is as follows (in thousands): Years Ended December 31, 2023 2022 2021 Income (loss) from operations $ 119,966 $ (161,201) $ (411,046) Research and development expenses (1) 306,560 265,808 237,189 General and administrative expenses (1) 343,126 365,768 295,071 Total stock-based compensation expense 475,903 564,798 778,215 Total contribution $ 1,245,555 $ 1,035,173 $ 899,429 ————— (1) Excludes stock-based compensation expense.
Summary of Revenue by Geography	Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages): Years Ended December 31, 2023 2022 2021 Amount % Amount % Amount % Revenue: United States $ 1,378,247 62 % $ 1,161,416 61 % $ 879,156 57 % United Kingdom 235,257 11 % 220,942 12 % 173,362 11 % Rest of world (1) 611,508 27 % 523,513 27 % 489,371 32 % Total revenue $ 2,225,012 100 % $ 1,905,871 100 % $ 1,541,889 100 % ————— (1) No other country represented 10% or more of total revenue for the years ended December 31, 2023 , 2022, or 2021 .
Summary of Property and Equipment, Net by Geography	Property and equipment, net is attributed to the Company’s office locations as follows (in thousands, except percentages): As of December 31, 2023 2022 Amount % Amount % Property and equipment, net: United States $ 28,825 60 % $ 46,599 67 % Japan 11,440 24 % 13,318 19 % United Kingdom 5,851 12 % 6,746 10 % Rest of world 1,642 4 % 2,507 4 % Total property and equipment, net $ 47,758 100 % $ 69,170 100 %

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
Intangible Assets (Tables)	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	Intangible assets subject to amortization that are not fully amortized are as follows (in thousands): Weighted average useful life As of December 31, 2023 As of December 31, 2022 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Customer relationships 3.83 $ 10,400 $ (2,427) $ 7,973 $ 10,400 $ (347) $ 10,053 Reacquired rights 5.83 17,618 (2,936) 14,682 17,619 (420) 17,199 Backlog 0.83 6,700 (3,908) 2,792 6,700 (558) 6,142 Other 0.27 4,225 (3,770) 455 5,717 (3,572) 2,145 Total intangible assets $ 38,943 $ (13,041) $ 25,902 $ 40,436 $ (4,897) $ 35,539
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of December 31, 2023, expected amortization expense for the unamortized finite-lived intangible assets for the next five years and thereafter is as follows (in thousands): Year ended December 31, Amount 2024 $ 7,844 2025 4,597 2026 4,597 2027 4,250 2028 2,517 Thereafter 2,097 Total $ 25,902

Significant Accounting Polici_4

Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	$ 831,047	$ 2,598,540	$ 2,290,674
Total cash, cash equivalents, and restricted cash	850,107	2,627,335	2,366,914	$ 2,128,146
Prepaid Expenses and Other Current Assets
Cash and Cash Equivalents [Line Items]
Restricted cash	370	16,244	36,628
Other Current Assets
Cash and Cash Equivalents [Line Items]
Restricted cash	$ 18,690	$ 12,551	$ 39,612

Significant Accounting Polici_5

Significant Accounting Policies - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($) segment	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Accounting Policies [Line Items]
Number of operating segments \| segment	2
Allowance for credit losses	$ 10,500	$ 10,100
Accounts receivable, net	$ 364,784	258,346
Useful lives (in years)	3 years
Advertising expense	$ 21,400	$ 38,600	$ 26,300
Minimum
Accounting Policies [Line Items]
Share based payment award vesting period	4 years
Maximum
Accounting Policies [Line Items]
Share based payment award vesting period	1 year
Leasehold improvements
Accounting Policies [Line Items]
Useful lives (in years)	5 years
Customer I \| Accounts Receivable Benchmark \| Customer Concentration Risk
Accounting Policies [Line Items]
Concentration risk (in percent)	15%

Contract Liabilities and Rema_2

Contract Liabilities and Remaining Performance Obligations - Additional information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Contract with customer, liability	$ 486.3	$ 339.2
Revenue recognized from contract liability balances	329.4	$ 384.3
Remaining performance obligation	$ 1,200
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation (as percent)	52%
Expected timing of satisfaction (in months)	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation (as percent)	37%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 \| Minimum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Expected timing of satisfaction (in months)	13 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 \| Maximum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Expected timing of satisfaction (in months)	36 months

Investments and Fair Value Me_3

Investments and Fair Value Measurements - Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Marketable securities:
Debt securities	$ 2,834,940,000	$ 0
Total	3,435,491,000	1,209,935,000
Revenues	2,225,012,000	1,905,871,000	$ 1,541,889,000
Level 1
Marketable securities:
Total	594,836,000	1,184,437,000
Level 2
Marketable securities:
Total	2,840,655,000	25,498,000
Level 3
Marketable securities:
Total	0	0
U.S. treasury securities
Marketable securities:
Debt securities	2,834,940,000
Cash and Cash Equivalents \| Money market funds
Cash and cash equivalents:
Cash and cash equivalents	576,565,000	1,149,302,000
Cash and Cash Equivalents \| Money market funds \| Level 1
Cash and cash equivalents:
Cash and cash equivalents	576,565,000	1,149,302,000
Cash and Cash Equivalents \| Money market funds \| Level 2
Cash and cash equivalents:
Cash and cash equivalents	0	0
Cash and Cash Equivalents \| Money market funds \| Level 3
Cash and cash equivalents:
Cash and cash equivalents	0	0
Cash and Cash Equivalents \| U.S. treasury securities
Cash and cash equivalents:
Cash and cash equivalents	10,079,000
Marketable securities:
Debt securities	10,079,000
Cash and Cash Equivalents \| U.S. treasury securities \| Level 1
Cash and cash equivalents:
Cash and cash equivalents	0
Cash and Cash Equivalents \| U.S. treasury securities \| Level 2
Cash and cash equivalents:
Cash and cash equivalents	10,079,000
Cash and Cash Equivalents \| U.S. treasury securities \| Level 3
Cash and cash equivalents:
Cash and cash equivalents	0
Cash and Cash Equivalents \| Certificates of deposit
Cash and cash equivalents:
Cash and cash equivalents	938,000	6,791,000
Cash and Cash Equivalents \| Certificates of deposit \| Level 1
Cash and cash equivalents:
Cash and cash equivalents	0	0
Cash and Cash Equivalents \| Certificates of deposit \| Level 2
Cash and cash equivalents:
Cash and cash equivalents	938,000	6,791,000
Cash and Cash Equivalents \| Certificates of deposit \| Level 3
Cash and cash equivalents:
Cash and cash equivalents	0	0
Prepaid Expenses and Other Current Assets and Other Assets \| Certificates of deposit
Prepaid expenses and other current assets and other assets:
Certificates of deposit	4,777,000	18,707,000
Prepaid Expenses and Other Current Assets and Other Assets \| Certificates of deposit \| Level 1
Prepaid expenses and other current assets and other assets:
Certificates of deposit	0	0
Prepaid Expenses and Other Current Assets and Other Assets \| Certificates of deposit \| Level 2
Prepaid expenses and other current assets and other assets:
Certificates of deposit	4,777,000	18,707,000
Prepaid Expenses and Other Current Assets and Other Assets \| Certificates of deposit \| Level 3
Prepaid expenses and other current assets and other assets:
Certificates of deposit	0	0
Marketable Securities \| U.S. treasury securities
Marketable securities:
Debt securities	2,824,861,000
Marketable Securities \| U.S. treasury securities \| Level 1
Marketable securities:
Debt securities	0
Marketable Securities \| U.S. treasury securities \| Level 2
Marketable securities:
Debt securities	2,824,861,000
Marketable Securities \| U.S. treasury securities \| Level 3
Marketable securities:
Debt securities	0
Marketable Securities \| U.S. treasury securities
Marketable securities:
U.S. treasury securities	18,271,000	35,135,000
Marketable Securities \| U.S. treasury securities \| Level 1
Marketable securities:
U.S. treasury securities	18,271,000	35,135,000
Marketable Securities \| U.S. treasury securities \| Level 2
Marketable securities:
U.S. treasury securities	0	0
Marketable Securities \| U.S. treasury securities \| Level 3
Marketable securities:
U.S. treasury securities	$ 0	$ 0

Investments and Fair Value Me_4

Investments and Fair Value Measurements - Available-For-Sale Debt Securities (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	$ 2,831,505,000
Unrealized Gains	4,520,000
Unrealized Losses	(1,085,000)
Fair Value	2,834,940,000	$ 0
U.S. treasury securities
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	2,831,505,000
Unrealized Gains	4,520,000
Unrealized Losses	(1,085,000)
Fair Value	2,834,940,000
U.S. treasury securities \| Cash and Cash Equivalents
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	10,078,000
Unrealized Gains	1,000
Unrealized Losses	0
Fair Value	10,079,000
U.S. treasury securities \| Current Marketable Securities
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	2,821,427,000
Unrealized Gains	4,519,000
Unrealized Losses	(1,085,000)
Fair Value	$ 2,824,861,000

Investments and Fair Value Me_5

Investments and Fair Value Measurements - Additional Information (Detail)	12 Months Ended			36 Months Ended
	Dec. 31, 2023 USD ($) security	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($) oz	Dec. 31, 2023 USD ($) security
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Proceeds from sale of available-for-sale securities	$ 694,600,000
Credit or non-credit losses related to debt securities	0
Available-for-sale debt securities in unrealized loss position	$ 236,000,000			$ 236,000,000
Number of securities in an unrealized loss position for greater than 12 months \| security	0			0
Debt securities	$ 2,834,940,000	$ 0		$ 2,834,940,000
Equity securities received as noncash consideration	41,700,000	6,800,000	$ 0
Unrealized gain (loss) from equity securities		(159,000,000)	(72,800,000)
Realized loss from equity securities		113,100,000
Realized gain (loss) for equity securities			0
Privately-held equity securities without readily determinable fair value, amount	32,600,000	24,400,000		32,600,000
Revenues	2,225,012,000	1,905,871,000	1,541,889,000
Investment in physical commodities			$ 50,900,000
Weight of commodities purchased \| oz			100
Proceeds from sales of alternative investments	51,100,000
Publicly-Traded Equity Securities Held
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unrealized gain (loss) from equity securities	(4,500,000)	(197,300,000)	$ (72,800,000)
Investment Agreement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate purchase price	0	$ 124,500,000		0
Commercial Contract \| Investment Agreement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Maximum contract value	376,500,000			376,500,000
Revenues	87,300,000			253,900,000
Commercial Contract \| Investment Agreement \| Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contractual option amounts	$ 40,400,000			$ 40,400,000
Subscription contract term	7 years
Commercial Contract \| Investment Agreement \| Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Subscription contract term	2 years

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Balance Sheet Related Disclosures [Line Items]
Total property and equipment, gross	$ 149,916	$ 151,582
Less: accumulated depreciation and amortization	(102,158)	(82,412)
Total property and equipment, net	47,758	69,170
Leasehold improvements
Balance Sheet Related Disclosures [Line Items]
Total property and equipment, gross	83,139	80,378
Computer equipment, software, and other
Balance Sheet Related Disclosures [Line Items]
Total property and equipment, gross	50,844	52,688
Furniture and fixtures
Balance Sheet Related Disclosures [Line Items]
Total property and equipment, gross	13,834	13,010
Construction in progress
Balance Sheet Related Disclosures [Line Items]
Total property and equipment, gross	$ 2,099	$ 5,506

Balance Sheet Components - Addi

Balance Sheet Components - Additional information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Balance Sheet Related Disclosures [Abstract]
Depreciation and amortization expense excluding the impact of foreign exchange fluctuations	$ 23.7	$ 19.5	$ 12.8

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Accrued Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Balance Sheet Related Disclosures [Abstract]
Accrued payroll and related expenses	$ 83,094	$ 43,495
Accrued taxes	47,257	41,326
Accrued other liabilities	92,640	87,894
Total accrued liabilities	$ 222,991	$ 172,715

Debt - Additional Information (

Debt - Additional Information (Detail) - 2014 Revolving Credit Facility - Line of Credit	12 Months Ended
	Dec. 31, 2023 USD ($)
Short-Term Debt [Line Items]
Debt instrument maximum borrowing capacity	$ 500,000,000
Revolving Credit Facility
Short-Term Debt [Line Items]
Debt instrument carrying amount	0
Line of credit minimum liquidity to be maintained	$ 50,000,000

Leases - Additional Information

Leases - Additional Information (Detail) $ in Millions	12 Months Ended
Leases - Additional Information (Detail) $ in Millions	Dec. 31, 2023 USD ($) option	Dec. 31, 2022
Leases [Abstract]
Number of options to extend leases \| option	1
Weighted average remaining lease term (in years)	6 years	7 years
Weighted average discount rate (in percent)	6%	6%
Leases not yet commenced \| $	$ 0

Leases - Summary Balance Sheet

Leases - Summary Balance Sheet Information Relating to Leases (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Lease-Related Assets and Liabilities
Operating lease right-of-use assets	$ 182,863	$ 200,240
Total right-of-use assets	182,863	200,240
Lease liabilities:
Operating lease liabilities	54,176	45,099
Operating lease liabilities, noncurrent	175,216	204,305
Total operating lease liabilities	$ 229,392	$ 249,404

Leases - Summary of Operating L

Leases - Summary of Operating Lease Cost (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Lease, Cost [Abstract]
Operating lease expense	$ 61,972	$ 55,483
Short-term lease expense	4,949	4,956
Variable lease expense	4,772	5,309
Sublease income	(18,905)	(13,011)
Total lease expense, net	$ 52,788	$ 52,737

Leases - Maturities of Operatin

Leases - Maturities of Operating Lease Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Operating Lease Commitments
2024	$ 67,420
2025	57,053
2026	40,068
2027	28,278
2028	21,816
Thereafter	62,116
Total undiscounted liabilities	276,751
Less: Imputed interest	(47,359)
Total operating lease liabilities	229,392	$ 249,404
Less: Sublease Income
2024	16,593
2025	14,357
2026	13,748
2027	14,423
2028	12,470
Thereafter	30,761
Total undiscounted liabilities	102,352
Less: Imputed interest	0
Total operating lease liabilities	102,352
Net Lease Commitments
2024	50,827
2025	42,696
2026	26,320
2027	13,855
2028	9,346
Thereafter	31,355
Total undiscounted liabilities	174,399
Less: Imputed interest	(47,359)
Total operating lease liabilities	$ 127,040

Leases - Summary of Supplementa

Leases - Summary of Supplemental Cash Flow Information Related to Operating Leases (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Cash paid for operating lease liabilities	$ 63,374	$ 53,772
Lease liabilities arising from obtaining right-of-use assets	$ 28,112	$ 28,169

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - Purchase Commitment Two - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2023
Purchase Commitment, Excluding Long-Term Commitment [Line Items]
Minimum annual commitment	$ 1,950
Period for purchase price commitment (in years)	10 years
Purchase commitment for current contract year		$ 40.7
Purchase commitment for year one	$ 154

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail)	12 Months Ended
Stockholders' Equity - Additional Information (Detail)	Dec. 31, 2023 USD ($) vote shares	Aug. 31, 2023 USD ($)
Class of Stock [Line Items]
Minimum ownership threshold (in shares) \| shares	100,000,000
Dividends declared \| $	$ 0
Stock repurchase program, authorized amount \| $		$ 1,000,000,000
Stock repurchased during period (in shares) \| shares	0
Class A Common Stock
Class of Stock [Line Items]
Voting rights \| vote	1
Class B Common Stock
Class of Stock [Line Items]
Voting rights \| vote	10
Common stock, convertible, conversion ratio	1
Class F Common Stock
Class of Stock [Line Items]
Control of total voting power	50%

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Total Authorized, Issued, And Outstanding Shares (Detail) - shares	Dec. 31, 2023	Dec. 31, 2022
Class of Stock [Line Items]
Authorized	22,701,005,000	22,701,005,000
Issued	2,200,128,000	2,099,075,000
Outstanding	2,200,128,000	2,099,075,000
Class A Common Stock
Class of Stock [Line Items]
Authorized	20,000,000,000	20,000,000,000
Issued	2,096,982,000	1,995,414,000
Outstanding	2,096,982,000	1,995,414,000
Class B Common Stock
Class of Stock [Line Items]
Authorized	2,700,000,000	2,700,000,000
Issued	102,141,000	102,656,000
Outstanding	102,141,000	102,656,000
Class F Common Stock
Class of Stock [Line Items]
Authorized	1,005,000	1,005,000
Issued	1,005,000	1,005,000
Outstanding	1,005,000	1,005,000

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail) - USD ($)		1 Months Ended	12 Months Ended
	Sep. 30, 2020	Aug. 30, 2020	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (in shares)			0	0	0
Options vested and exercisable (in years)			6 years 11 months 4 days
Aggregate intrinsic value of options exercised			$ 476,800,000	$ 112,300,000	$ 3,800,000,000
Grant date fair value of stock options vested during period			131,000,000	170,800,000	189,500,000
Unrecognized share based compensation expense			$ 599,100,000
Unrecognized share based compensation expense, period for recognition (in years)			7 years
Tax benefits related to stock-based compensation expense			$ 0	0	0
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based payment award vesting period			4 years
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based payment award vesting period			1 year
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in period (in shares)			19,484,000
Unrecognized share based compensation expense			$ 566,400,000
Share based payment award vesting period			4 years
Vested in period			$ 526,100,000	$ 453,200,000	$ 421,000,000
Unrecognized share based compensation expense, period for recognition (in years)			3 years
P-RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in period (in shares)			1,976,000
Unrecognized share based compensation expense			$ 0
Share based payment award vesting period			3 months
P-RSUs \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance target (in percent)			0%
P-RSUs \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance target (in percent)			100%
2020 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)	150,000,000	165,900,000
Options granted (in shares)		162,000,000
Outstanding stock maximum (in percent)	5%
Ownership (in percent)			10%
2020 Equity Incentive Plan \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of common stock (in percent)			110%
2020 Equity Incentive Plan \| Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Additional shares authorized (in shares)	250,000,000
Expiration period (in years)			10 years
2020 Equity Incentive Plan \| Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in period (in shares)		3,900,000
2020 Extended Exercisability
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period (in years)			5 years
Options vested and exercisable (in years)			4 years

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Stock Option Activity (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Options Outstanding
Beginning balance (in shares)	326,913,000
Options exercised (in shares)	(46,079,000)
Options canceled and forfeited (in shares)	(2,364,000)
Ending balance (in shares)	278,470,000	326,913,000
Options vested and exercisable, end of period (in shares)	160,877,000
Weighted-Average Exercise Price Per Share
Beginning balance (in dollars per share)	$ 8.05
Options exercised (in dollars per share)	4.74
Options canceled and forfeited (in dollars per share)	5.39
Ending balance (in dollars per share)	8.62	$ 8.05
Options vested and exercisable, end of period (in dollars per share)	$ 6.66
Weighted-Average Remaining Contractual Life (years) and Aggregate Intrinsic Value
Options outstanding, Weighted-average remaining contractual life (in years)	7 years 7 months 20 days	8 years 3 months 29 days
Options vested and exercisable (in years)	6 years 11 months 4 days
Options outstanding, aggregate intrinsic value	$ 2,381,172	$ 272,603
Options vested and exercisable, end of period	$ 1,691,404

Stock-Based Compensation - Su_2

Stock-Based Compensation - Summary of RSU And PRSU Activity (Detail)	12 Months Ended
	Dec. 31, 2023 $ / shares shares
RSUs
Units Outstanding
Unvested and outstanding, beginning balance (in shares) \| shares	126,426,000
Granted (in shares) \| shares	19,484,000
Vested and converted to shares (in shares) \| shares	(54,974,000)
Canceled (in shares) \| shares	(8,674,000)
Unvested and outstanding, ending balance (in shares) \| shares	82,262,000
Weighted Average Grant Date Fair Value per Share
Unvested and outstanding, beginning balance (in dollars per share) \| $ / shares	$ 10.07
Granted (in dollars per share) \| $ / shares	11.77
Vested and converted to shares (in dollars per share) \| $ / shares	9.57
Cancelled (in dollars per share) \| $ / shares	11.08
Unvested and outstanding, ending balance (in dollars per share) \| $ / shares	$ 10.71
P-RSUs
Units Outstanding
Unvested and outstanding, beginning balance (in shares) \| shares	0
Granted (in shares) \| shares	1,976,000
Vested and converted to shares (in shares) \| shares	0
Canceled (in shares) \| shares	0
Unvested and outstanding, ending balance (in shares) \| shares	1,976,000
Weighted Average Grant Date Fair Value per Share
Unvested and outstanding, beginning balance (in dollars per share) \| $ / shares	$ 0
Granted (in dollars per share) \| $ / shares	15.39
Vested and converted to shares (in dollars per share) \| $ / shares	0
Cancelled (in dollars per share) \| $ / shares	0
Unvested and outstanding, ending balance (in dollars per share) \| $ / shares	$ 15.39

Stock-Based Compensation - Su_3

Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 475,903	$ 564,798	$ 778,215
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	35,995	44,061	68,546
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	160,645	196,301	242,910
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	98,064	93,871	150,298
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 181,199	$ 230,565	$ 316,461

Income Taxes - Summary of Loss

Income Taxes - Summary of Loss Before Provision for (benefit from) Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Schedule of Income (Loss) before Income Tax, Domestic and Foreign [Line Items]
Income (loss) before provision for income taxes	$ 237,091	$ (361,027)	$ (488,494)
United States
Schedule of Income (Loss) before Income Tax, Domestic and Foreign [Line Items]
Income (loss) before provision for income taxes	174,637	(402,834)	(514,200)
Foreign
Schedule of Income (Loss) before Income Tax, Domestic and Foreign [Line Items]
Income (loss) before provision for income taxes	$ 62,454	$ 41,807	$ 25,706

Income Taxes - Summary of Provi

Income Taxes - Summary of Provision for (benefit from) Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Current:
Federal	$ 0	$ 0	$ 0
State	2,333	765	(88)
Foreign	22,189	9,476	(11,343)
Total current provision	24,522	10,241	(11,431)
Deferred:
Federal	0	0	(111)
State	0	0	0
Foreign	(4,806)	(174)	43,427
Deferred income taxes	(4,806)	(174)	43,316
Total provision for income taxes	$ 19,716	$ 10,067	$ 31,885

Income Taxes - Summary of Recon

Income Taxes - Summary of Reconciliation of Effective Income Tax Rate (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Effective Income Tax Rate Reconciliation, Amount [Abstract]
Expected tax (benefit) at U.S. federal statutory rate	$ 49,789	$ (75,592)	$ (102,584)
State income taxes - net of federal benefit	2,309	766	(88)
Foreign tax rate differential	859	832	870
Research and development tax credits	(45,667)	(34,546)	(94,591)
Stock-based compensation	(79,128)	1,374	(817,839)
Non-deductible officers’ compensation	34,479	40,629	428,682
Change in valuation allowance	35,070	49,833	616,572
Base Erosion Anti-Abuse Tax and related elections	14,700	25,200	0
Taxes withheld at source	4,378	0	0
Non-deductible expenses	3,610	0	0
Other	(683)	1,571	863
Total provision for income taxes	$ 19,716	$ 10,067	$ 31,885

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Contingency [Line Items]
Total provision for income taxes	$ 19,716	$ 10,067	$ 31,885
Valuation allowance	2,102,251	2,051,655
Valuation allowance, increase (decrease)	50,600	74,100
Capitalized research and experimental expenses	214,848	70,839
Outside basis difference	0	(6,512)
Unrecognized tax benefits	112,016	81,904	$ 65,070	$ 75,557
United States
Income Tax Contingency [Line Items]
Net operating loss carryforwards	324,000	113,100
Non-US
Income Tax Contingency [Line Items]
Net operating loss carryforwards	464,700
California Franchise Tax Board
Income Tax Contingency [Line Items]
Deferred tax assets, tax credit carryforwards, research	99,500	91,400
Domestic Tax Authority
Income Tax Contingency [Line Items]
Net operating loss carryforwards	5,000,000	5,600,000
Operating loss carryforwards, not subject to expiration	4,200,000
Deferred tax assets, tax credit carryforwards, research	290,100	230,200
State and Local Jurisdiction \| California Franchise Tax Board
Income Tax Contingency [Line Items]
Net operating loss carryforwards	$ 2,500,000	$ 2,800,000

Income Taxes - Summary of Signi

Income Taxes - Summary of Significant Deferred Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Components of Deferred Tax Assets and Liabilities [Abstract]
Net operating loss carryforwards	$ 1,317,684	$ 1,436,957
Capitalized research and experimental expenses	214,848	70,839
Reserves and accruals	99,105	76,905
Tax credit carryforwards	277,060	226,565
Stock-based compensation	139,419	203,735
Lease liabilities	53,902	58,056
Depreciation and amortization	14,413	29,665
Capitalized facilitative expenses	28,906	0
Gross deferred tax assets	2,145,337	2,102,722
Outside basis difference	0	(6,512)
Acquisition related intangibles	(8,428)	(10,225)
Right-of-use assets	(42,721)	(46,295)
Total net deferred tax assets before valuation allowance	2,094,188	2,039,690
Valuation allowance	(2,102,251)	(2,051,655)
Net deferred tax assets (liabilities)	$ (8,063)	$ (11,965)

Income Taxes - Summary of Rec_2

Income Taxes - Summary of Reconciliation of the Gross Unrecognized Tax Benefits (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Unrecognized tax benefit beginning of year	$ 81,904	$ 65,070	$ 75,557
Increases in current year tax positions	14,346	5,733	19,638
Increases in prior year tax positions	15,766	11,497	967
Decreases in prior year tax positions	0	(36)	(30,895)
Decreases in prior year tax positions due to settlements	0	(360)	(197)
Decreases in prior year tax positions due to lapse of statute of limitations	0	0	0
Unrecognized tax benefit end of year	$ 112,016	$ 81,904	$ 65,070

Net Earnings (Loss) Per Share_3

Net Earnings (Loss) Per Share Attributable to Common Stockholders - Summary of Calculation of Basic and Diluted Net Loss Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Numerator
Net income (loss) attributable to common stockholders for diluted net earnings (loss) per share	$ 209,825	$ (373,705)	$ (520,379)
Denominator
Weighted-average shares used in computing net earnings (loss) per share, basic (in shares)	2,147,446	2,063,793	1,923,617
Effect of dilutive shares	150,481	0	0
Weighted-average shares used in computing net earnings (loss) per share, diluted (in shares)	2,297,927	2,063,793	1,923,617
Net earnings (loss) per share
Net earnings (loss) per share attributable to common stockholders, basic (in dollars per share)	$ 0.10	$ (0.18)	$ (0.27)
Net earnings (loss) per share attributable to common stockholders, diluted (in dollars per share)	$ 0.09	$ (0.18)	$ (0.27)

Net Earnings (Loss) Per Share_4

Net Earnings (Loss) Per Share Attributable to Common Stockholders - Summary of Antidilutive Securities (Detail) - shares shares in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	175,245	466,381	516,768
Options and SARs issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	162,000	326,913	349,977
RSUs and P-RSUs outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	13,245	126,426	153,749
Warrants to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	13,042	13,042

Segment and Geographic Inform_3

Segment and Geographic Information - Summary of Financial Information for Each Reportable Segment (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Revenues	$ 2,225,012	$ 1,905,871	$ 1,541,889
Operating Segments
Segment Reporting Information [Line Items]
Revenues	2,225,012	1,905,871	1,541,889
Total contribution	$ 1,245,555	$ 1,035,173	$ 899,429
Contribution margin (in percent)	56%	54%	58%
Operating Segments \| Government
Segment Reporting Information [Line Items]
Revenues	$ 1,222,215	$ 1,071,776	$ 897,356
Total contribution	$ 724,970	$ 620,677	$ 541,883
Contribution margin (in percent)	59%	58%	60%
Operating Segments \| Commercial
Segment Reporting Information [Line Items]
Revenues	$ 1,002,797	$ 834,095	$ 644,533
Total contribution	$ 520,585	$ 414,496	$ 357,546
Contribution margin (in percent)	52%	50%	55%

Segment and Geographic Inform_4

Segment and Geographic Information - Summary of Reconciliation of Segment Financial Information to Loss from Operations (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Income (loss) from operations	$ 119,966	$ (161,201)	$ (411,046)
Total stock-based compensation expense	475,903	564,798	778,215
Reconciling items
Segment Reporting Information [Line Items]
Income (loss) from operations	119,966	(161,201)	(411,046)
Research and development expenses	306,560	265,808	237,189
General and administrative expenses	343,126	365,768	295,071
Total stock-based compensation expense	475,903	564,798	778,215
Operating Segments
Segment Reporting Information [Line Items]
Total contribution	$ 1,245,555	$ 1,035,173	$ 899,429

Segment and Geographic Inform_5

Segment and Geographic Information - Summary of Revenue by Geography (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Revenues	$ 2,225,012	$ 1,905,871	$ 1,541,889
Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenues	$ 2,225,012	$ 1,905,871	$ 1,541,889
Geographic Concentration Risk \| Revenue Benchmark
Disaggregation of Revenue [Line Items]
Concentration risk (in percent)	100%	100%	100%
Geographic Concentration Risk \| Revenue Benchmark \| Minimum
Disaggregation of Revenue [Line Items]
Concentration risk (in percent)	10%	10%	10%
United States \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenues	$ 1,378,247	$ 1,161,416	$ 879,156
United States \| Geographic Concentration Risk \| Revenue Benchmark
Disaggregation of Revenue [Line Items]
Concentration risk (in percent)	62%	61%	57%
United Kingdom \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenues	$ 235,257	$ 220,942	$ 173,362
United Kingdom \| Geographic Concentration Risk \| Revenue Benchmark
Disaggregation of Revenue [Line Items]
Concentration risk (in percent)	11%	12%	11%
Rest of world \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenues	$ 611,508	$ 523,513	$ 489,371
Rest of world \| Geographic Concentration Risk \| Revenue Benchmark
Disaggregation of Revenue [Line Items]
Concentration risk (in percent)	27%	27%	32%

Segment and Geographic Inform_6

Segment and Geographic Information - Summary of Property and Equipment, Net by Geography (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting, Other Significant Reconciling Item [Line Items]
Property and equipment, net	$ 47,758	$ 69,170
Geographic Concentration Risk
Segment Reporting, Other Significant Reconciling Item [Line Items]
Property and equipment, net	$ 47,758	$ 69,170
Geographic Concentration Risk \| Property, Plant and Equipment
Segment Reporting, Other Significant Reconciling Item [Line Items]
Concentration risk (in percent)	100%	100%
United States \| Geographic Concentration Risk
Segment Reporting, Other Significant Reconciling Item [Line Items]
Property and equipment, net	$ 28,825	$ 46,599
United States \| Geographic Concentration Risk \| Property, Plant and Equipment
Segment Reporting, Other Significant Reconciling Item [Line Items]
Concentration risk (in percent)	60%	67%
Japan \| Geographic Concentration Risk
Segment Reporting, Other Significant Reconciling Item [Line Items]
Property and equipment, net	$ 11,440	$ 13,318
Japan \| Geographic Concentration Risk \| Property, Plant and Equipment
Segment Reporting, Other Significant Reconciling Item [Line Items]
Concentration risk (in percent)	24%	19%
United Kingdom \| Geographic Concentration Risk
Segment Reporting, Other Significant Reconciling Item [Line Items]
Property and equipment, net	$ 5,851	$ 6,746
United Kingdom \| Geographic Concentration Risk \| Property, Plant and Equipment
Segment Reporting, Other Significant Reconciling Item [Line Items]
Concentration risk (in percent)	12%	10%
Rest of world \| Geographic Concentration Risk
Segment Reporting, Other Significant Reconciling Item [Line Items]
Property and equipment, net	$ 1,642	$ 2,507
Rest of world \| Geographic Concentration Risk \| Property, Plant and Equipment
Segment Reporting, Other Significant Reconciling Item [Line Items]
Concentration risk (in percent)	4%	4%

Business Combinations - Narrati

Business Combinations - Narrative (Details) - USD ($)		12 Months Ended
Business Combinations - Narrative (Details) - USD ($)	Nov. 08, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Gain from step acquisition		$ 0	$ 44,306,000	$ 0
Palantir Technologies Japan, K.K.
Business Acquisition [Line Items]
Fair value on acquisition date	$ 149,000,000
Equity interest immediately prior to the acquisition	74,500,000
Noncontrolling interest	74,500,000
Recognized identifiable assets acquired and liabilities assumed, cash	66,700,000
Goodwill	36,100,000
Recognized identifiable assets acquired and liabilities assumed, liabilities	$ 21,000,000
Goodwill recognized expected to be deductible for income tax purposes		$ 0
Gain from step acquisition			$ 44,300,000
Palantir Technologies Japan, K.K. \| Minimum
Business Acquisition [Line Items]
Amortization period of finite-intangible assets (in years)	2 years
Palantir Technologies Japan, K.K. \| Maximum
Business Acquisition [Line Items]
Amortization period of finite-intangible assets (in years)	7 years
Palantir Technologies Japan, K.K. \| Customer Relationships, Reacquired Rights, Backlog
Business Acquisition [Line Items]
Recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles	$ 34,700,000
Palantir Technologies Japan, K.K. \| Other
Business Acquisition [Line Items]
Recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles	$ 32,500,000
Palantir Technologies Japan, K.K.
Business Acquisition [Line Items]
Ownership percentage (in percent)	50%

Intangible Assets - Schedule of

Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 38,943	$ 40,436
Accumulated Amortization	(13,041)	(4,897)
Total	$ 25,902	35,539
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life	3 years 9 months 29 days
Gross Carrying Amount	$ 10,400	10,400
Accumulated Amortization	(2,427)	(347)
Total	$ 7,973	10,053
Reacquired rights
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life	5 years 9 months 29 days
Gross Carrying Amount	$ 17,618	17,619
Accumulated Amortization	(2,936)	(420)
Total	$ 14,682	17,199
Backlog
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life	9 months 29 days
Gross Carrying Amount	$ 6,700	6,700
Accumulated Amortization	(3,908)	(558)
Total	$ 2,792	6,142
Other
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life	3 months 7 days
Gross Carrying Amount	$ 4,225	5,717
Accumulated Amortization	(3,770)	(3,572)
Total	$ 455	$ 2,145

Intangible Assets - Narrative (

Intangible Assets - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense of intangible assets	$ 9.6	$ 0

Intangible Assets - Expected Am

Intangible Assets - Expected Amortization Expense (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2024	$ 7,844
2025	4,597
2026	4,597
2027	4,250
2028	2,517
Thereafter	2,097
Total	$ 25,902	$ 35,539